Symbol:
Adgrl3
Name:
adhesion G protein-coupled receptor L3
RGD ID:
620836
Description:
Predicted to enable G protein-coupled receptor activity and calcium ion binding activity. Predicted to be involved in several processes, including locomotion involved in locomotory behavior; response to cocaine; and synapse organization. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in membrane. Predicted to be active in several cellular components, including Schaffer collateral - CA1 synapse; glutamatergic synapse; and postsynaptic membrane. Orthologous to human ADGRL3 (adhesion G protein-coupled receptor L3); INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
calcium-independent alpha-latrotoxin receptor 3; calcium-independent alpha-latrotoxin receptor homolog 3; CIRL-3; Cirl3; latrophilin 3; latrophilin-3; Lec3; lectomedin-3; Lphn3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Allele / Splice:
Adgrl3Tn(sb-T2/Bart3)2.151Mcwi ;
Adgrl3em1Huyc
Genetic Models:
F344-Adgrl3Tn(sb-T2/Bart3)2.151Mcwi ;
SD-Adgrl3em1Huyc
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 26,690,891 - 27,458,132 (-) NCBI GRCr8 mRatBN7.2 14 26,336,320 - 27,104,060 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 26,368,277 - 27,105,860 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 26,715,441 - 27,465,812 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 28,027,851 - 28,778,270 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 26,509,623 - 27,260,039 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 28,362,176 - 29,226,085 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 28,393,394 - 28,967,980 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 28,183,727 - 29,040,121 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 28,385,112 - 28,854,677 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 28,385,120 - 28,854,677 (-) NCBI Celera 14 25,731,451 - 26,185,004 (-) NCBI Celera Cytogenetic Map 14 p21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Adgrl3 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ADGRL3 mRNA CTD PMID:15901920 Adgrl3 Rat 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ADGRL3 mRNA CTD PMID:26865667 Adgrl3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1553247 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRL3 mRNA CTD PMID:19465110 Adgrl3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADGRL3 mRNA CTD PMID:32109520 Adgrl3 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ADGRL3 mRNA CTD PMID:32109520 Adgrl3 Rat 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1553247 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADGRL3 mRNA CTD PMID:20188158 Adgrl3 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Adgrl3 Rat 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ADGRL3 mRNA CTD PMID:24780913 Adgrl3 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of LPHN3 mRNA CTD PMID:30047161 Adgrl3 Rat aflatoxin B1 increases methylation ISO RGD:1353351 6480464 Aflatoxin B1 results in increased methylation of ADGRL3 intron CTD PMID:30157460 Adgrl3 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRL3 mRNA CTD PMID:35163327 Adgrl3 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of ADGRL3 mRNA; Amitrole results in decreased expression of LPHN3 more ... CTD PMID:30047161|PMID:38685447 Adgrl3 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ADGRL3 mRNA CTD PMID:16483693 Adgrl3 Rat antirheumatic drug increases expression ISO RGD:1353351 6480464 Antirheumatic Agents results in increased expression of ADGRL3 mRNA CTD PMID:24449571 Adgrl3 Rat aristolochic acid A decreases expression ISO RGD:1353351 6480464 aristolochic acid I results in decreased expression of ADGRL3 mRNA CTD PMID:33212167 Adgrl3 Rat arsane decreases expression ISO RGD:1553247 6480464 Arsenic results in decreased expression of ADGRL3 mRNA CTD PMID:19654921 Adgrl3 Rat arsenic atom decreases expression ISO RGD:1553247 6480464 Arsenic results in decreased expression of ADGRL3 mRNA CTD PMID:19654921 Adgrl3 Rat belinostat decreases expression ISO RGD:1353351 6480464 belinostat results in decreased expression of ADGRL3 mRNA CTD PMID:26272509 Adgrl3 Rat belinostat multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Adgrl3 Rat benzo[a]pyrene decreases expression ISO RGD:1553247 6480464 Benzo(a)pyrene results in decreased expression of ADGRL3 mRNA CTD PMID:21569818 Adgrl3 Rat benzo[a]pyrene decreases methylation ISO RGD:1553247 6480464 Benzo(a)pyrene results in decreased methylation of LPHN3 intron CTD PMID:27901495 Adgrl3 Rat benzo[a]pyrene increases methylation ISO RGD:1353351 6480464 Benzo(a)pyrene results in increased methylation of LPHN3 promoter CTD PMID:27901495 Adgrl3 Rat benzo[a]pyrene increases expression ISO RGD:1553247 6480464 Benzo(a)pyrene results in increased expression of ADGRL3 mRNA CTD PMID:22610609|PMID:32417428 Adgrl3 Rat bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1553247 6480464 Diethylhexyl Phthalate results in decreased expression of ADGRL3 mRNA CTD PMID:33754040 Adgrl3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ADGRL3 mRNA CTD PMID:25181051 Adgrl3 Rat bisphenol A increases expression ISO RGD:1553247 6480464 bisphenol A results in increased expression of ADGRL3 mRNA CTD PMID:32156529 Adgrl3 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Adgrl3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADGRL3 mRNA CTD PMID:30816183 Adgrl3 Rat bisphenol F decreases methylation ISO RGD:1353351 6480464 bisphenol F results in decreased methylation of ADGRL3 gene CTD PMID:31601247 Adgrl3 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Adgrl3 Rat cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of ADGRL3 promoter CTD PMID:22457795 Adgrl3 Rat carbon nanotube decreases expression ISO RGD:1553247 6480464 Nanotubes, Carbon analog results in decreased expression of ADGRL3 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 Adgrl3 Rat CGP 52608 multiple interactions ISO RGD:1353351 6480464 CGP 52608 promotes the reaction [RORA protein binds to LPHN3 gene] CTD PMID:28238834 Adgrl3 Rat chloroprene increases expression ISO RGD:1553247 6480464 Chloroprene results in increased expression of ADGRL3 mRNA CTD PMID:23125180 Adgrl3 Rat cocaine affects expression EXP 6480464 Cocaine affects the expression of ADGRL3 mRNA CTD PMID:20187946 Adgrl3 Rat coumarin increases phosphorylation ISO RGD:1353351 6480464 coumarin results in increased phosphorylation of ADGRL3 protein CTD PMID:35688186 Adgrl3 Rat crocidolite asbestos decreases expression ISO RGD:1553247 6480464 Asbestos, Crocidolite results in decreased expression of ADGRL3 mRNA CTD PMID:29279043 Adgrl3 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ADGRL3 mRNA CTD PMID:27523638 Adgrl3 Rat cyclosporin A decreases expression ISO RGD:1353351 6480464 Cyclosporine results in decreased expression of ADGRL3 mRNA CTD PMID:20106945 Adgrl3 Rat dichloroacetic acid decreases expression ISO RGD:1553247 6480464 Dichloroacetic Acid results in decreased expression of ADGRL3 mRNA CTD PMID:28962523 Adgrl3 Rat dorsomorphin multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Adgrl3 Rat doxorubicin decreases expression ISO RGD:1353351 6480464 Doxorubicin results in decreased expression of ADGRL3 mRNA CTD PMID:29803840 Adgrl3 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ADGRL3 mRNA CTD PMID:29391264 Adgrl3 Rat entinostat multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Adgrl3 Rat entinostat decreases expression ISO RGD:1353351 6480464 entinostat results in decreased expression of ADGRL3 mRNA CTD PMID:26272509 Adgrl3 Rat ethanol increases expression ISO RGD:1553247 6480464 Ethanol results in increased expression of ADGRL3 mRNA CTD PMID:30319688 Adgrl3 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ADGRL3 mRNA CTD PMID:30307764 Adgrl3 Rat folic acid decreases expression ISO RGD:1553247 6480464 Folic Acid results in decreased expression of LPHN3 mRNA CTD PMID:25629700 Adgrl3 Rat fulvestrant decreases methylation ISO RGD:1353351 6480464 Fulvestrant results in decreased methylation of ADGRL3 gene CTD PMID:31601247 Adgrl3 Rat genistein decreases expression ISO RGD:1353351 6480464 Genistein results in decreased expression of ADGRL3 mRNA CTD PMID:26865667 Adgrl3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ADGRL3 mRNA CTD PMID:22061828 Adgrl3 Rat glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of ADGRL3 gene CTD PMID:35440735 Adgrl3 Rat hexane-1,6-diamine increases abundance ISO RGD:1353351 6480464 ADGRL3 gene modified form results in increased abundance of 1,6-diaminohexane CTD PMID:25445006 Adgrl3 Rat maneb multiple interactions ISO RGD:1553247 6480464 [Maneb co-treated with Paraquat] results in increased expression of ADGRL3 mRNA CTD PMID:36117858 Adgrl3 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of ADGRL3 mRNA; Methimazole results in decreased expression of LPHN3 more ... CTD PMID:30047161|PMID:38685447 Adgrl3 Rat methylmercury chloride decreases expression ISO RGD:1353351 6480464 methylmercuric chloride results in decreased expression of ADGRL3 mRNA CTD PMID:28001369 Adgrl3 Rat methylseleninic acid increases expression ISO RGD:1353351 6480464 methylselenic acid results in increased expression of ADGRL3 mRNA CTD PMID:18548127 Adgrl3 Rat Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of ADGRL3 mRNA CTD PMID:29162477 Adgrl3 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ADGRL3 gene CTD PMID:33148267 Adgrl3 Rat nickel atom decreases expression ISO RGD:1353351 6480464 Nickel results in decreased expression of ADGRL3 mRNA CTD PMID:24768652|PMID:25583101 Adgrl3 Rat okadaic acid decreases expression ISO RGD:1353351 6480464 Okadaic Acid results in decreased expression of ADGRL3 mRNA CTD PMID:38832940 Adgrl3 Rat ozone decreases expression ISO RGD:1553247 6480464 Ozone results in decreased expression of ADGRL3 mRNA CTD PMID:31626304 Adgrl3 Rat ozone multiple interactions ISO RGD:1553247 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Adgrl3 Rat panobinostat decreases expression ISO RGD:1353351 6480464 panobinostat results in decreased expression of ADGRL3 mRNA CTD PMID:26272509 Adgrl3 Rat panobinostat multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Adgrl3 Rat paraquat multiple interactions ISO RGD:1553247 6480464 [Maneb co-treated with Paraquat] results in increased expression of ADGRL3 mRNA CTD PMID:36117858 Adgrl3 Rat perfluorohexanesulfonic acid decreases expression ISO RGD:1553247 6480464 perfluorohexanesulfonic acid results in decreased expression of ADGRL3 mRNA CTD PMID:37995155 Adgrl3 Rat perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ADGRL3 mRNA CTD PMID:35163327 Adgrl3 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRL3 mRNA CTD PMID:35163327 Adgrl3 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ADGRL3 gene CTD PMID:33148267 Adgrl3 Rat pirinixic acid decreases expression ISO RGD:1553247 6480464 pirinixic acid results in decreased expression of ADGRL3 mRNA CTD PMID:20813756 Adgrl3 Rat potassium dichromate affects expression ISO RGD:1553247 6480464 Potassium Dichromate affects the expression of ADGRL3 mRNA CTD PMID:23608068 Adgrl3 Rat SB 431542 multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Adgrl3 Rat silicon dioxide decreases expression ISO RGD:1353351 6480464 Silicon Dioxide analog results in decreased expression of ADGRL3 mRNA CTD PMID:25895662 Adgrl3 Rat silver atom decreases expression ISO RGD:1553247 6480464 Silver results in decreased expression of ADGRL3 mRNA CTD PMID:27131904 Adgrl3 Rat silver(0) decreases expression ISO RGD:1553247 6480464 Silver results in decreased expression of ADGRL3 mRNA CTD PMID:27131904 Adgrl3 Rat sodium arsenite decreases expression ISO RGD:1353351 6480464 sodium arsenite results in decreased expression of ADGRL3 mRNA CTD PMID:38568856 Adgrl3 Rat sotorasib multiple interactions ISO RGD:1353351 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ADGRL3 mRNA CTD PMID:36139627 Adgrl3 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of LPHN3 mRNA CTD PMID:30047161 Adgrl3 Rat sulforaphane decreases expression ISO RGD:1553247 6480464 sulforaphane results in decreased expression of ADGRL3 mRNA CTD PMID:30529165 Adgrl3 Rat sunitinib decreases expression ISO RGD:1353351 6480464 Sunitinib results in decreased expression of ADGRL3 mRNA CTD PMID:31533062 Adgrl3 Rat thimerosal increases expression ISO RGD:1353351 6480464 Thimerosal results in increased expression of ADGRL3 mRNA CTD PMID:27188386 Adgrl3 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ADGRL3 mRNA CTD PMID:34492290 Adgrl3 Rat thiram decreases expression ISO RGD:1353351 6480464 Thiram results in decreased expression of ADGRL3 mRNA CTD PMID:38568856 Adgrl3 Rat titanium dioxide affects expression ISO RGD:1553247 6480464 titanium dioxide affects the expression of ADGRL3 mRNA CTD PMID:23557971 Adgrl3 Rat titanium dioxide decreases methylation ISO RGD:1553247 6480464 titanium dioxide results in decreased methylation of LPHN3 gene CTD PMID:35295148 Adgrl3 Rat titanium dioxide increases methylation ISO RGD:1553247 6480464 titanium dioxide results in increased methylation of LPHN3 promoter CTD PMID:35295148 Adgrl3 Rat trametinib multiple interactions ISO RGD:1353351 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ADGRL3 mRNA CTD PMID:36139627 Adgrl3 Rat tremolite asbestos decreases expression ISO RGD:1553247 6480464 tremolite results in decreased expression of ADGRL3 mRNA CTD PMID:29279043 Adgrl3 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ADGRL3 mRNA CTD PMID:33387578 Adgrl3 Rat trichostatin A multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Adgrl3 Rat trichostatin A decreases expression ISO RGD:1353351 6480464 trichostatin A results in decreased expression of ADGRL3 mRNA CTD PMID:24935251|PMID:26272509 Adgrl3 Rat triptonide affects expression ISO RGD:1553247 6480464 triptonide affects the expression of ADGRL3 mRNA CTD PMID:33045310 Adgrl3 Rat valproic acid affects expression ISO RGD:1353351 6480464 Valproic Acid affects the expression of ADGRL3 mRNA CTD PMID:25979313 Adgrl3 Rat valproic acid decreases expression ISO RGD:1353351 6480464 Valproic Acid results in decreased expression of ADGRL3 mRNA CTD PMID:23179753|PMID:26272509|PMID:27188386 Adgrl3 Rat valproic acid multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Adgrl3 Rat vorinostat decreases expression ISO RGD:1353351 6480464 vorinostat results in decreased expression of ADGRL3 mRNA CTD PMID:26272509|PMID:27188386 Adgrl3 Rat vorinostat multiple interactions ISO RGD:1353351 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386
17alpha-ethynylestradiol (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 3,4-methylenedioxymethamphetamine (ISO) 4,4'-sulfonyldiphenol (EXP) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) alpha-Zearalanol (EXP) amitrole (EXP) ammonium chloride (EXP) antirheumatic drug (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) belinostat (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) cadmium dichloride (EXP) carbon nanotube (ISO) CGP 52608 (ISO) chloroprene (ISO) cocaine (EXP) coumarin (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) cyclosporin A (ISO) dichloroacetic acid (ISO) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) entinostat (ISO) ethanol (ISO) fenvalerate (EXP) folic acid (ISO) fulvestrant (ISO) genistein (ISO) gentamycin (EXP) glyphosate (EXP) hexane-1,6-diamine (ISO) maneb (ISO) methimazole (EXP) methylmercury chloride (ISO) methylseleninic acid (ISO) Monobutylphthalate (EXP) N,N-diethyl-m-toluamide (EXP) nickel atom (ISO) okadaic acid (ISO) ozone (ISO) panobinostat (ISO) paraquat (ISO) perfluorohexanesulfonic acid (ISO) perfluorooctanoic acid (EXP) permethrin (EXP) pirinixic acid (ISO) potassium dichromate (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sotorasib (ISO) sulfadimethoxine (EXP) sulforaphane (ISO) sunitinib (ISO) thimerosal (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) trametinib (ISO) tremolite asbestos (ISO) trichloroethene (EXP) trichostatin A (ISO) triptonide (ISO) valproic acid (ISO) vorinostat (ISO)
1.
Involvement of the calcium-independent receptor for alpha-latrotoxin in brain ischemia.
Bin Sun H, etal., Brain Res Mol Brain Res. 2002 Aug 15;104(2):246-9.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors.
Ichtchenko K, etal., J Biol Chem 1999 Feb 26;274(9):5491-8.
4.
The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins.
Kreienkamp HJ, etal., J Biol Chem. 2000 Oct 20;275(42):32387-90.
5.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
6.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
7.
Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.
Regan SL, etal., Neurobiol Dis. 2019 Oct;130:104494. doi: 10.1016/j.nbd.2019.104494. Epub 2019 Jun 6.
8.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
9.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
10.
Comprehensive gene review and curation
RGD comprehensive gene curation
Adgrl3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 14 26,690,891 - 27,458,132 (-) NCBI GRCr8 mRatBN7.2 14 26,336,320 - 27,104,060 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 14 26,368,277 - 27,105,860 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 14 26,715,441 - 27,465,812 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 14 28,027,851 - 28,778,270 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 14 26,509,623 - 27,260,039 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 14 28,362,176 - 29,226,085 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 14 28,393,394 - 28,967,980 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 14 28,183,727 - 29,040,121 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 14 28,385,112 - 28,854,677 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 14 28,385,120 - 28,854,677 (-) NCBI Celera 14 25,731,451 - 26,185,004 (-) NCBI Celera Cytogenetic Map 14 p21 NCBI
ADGRL3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 4 61,200,326 - 62,078,335 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 4 61,200,326 - 62,078,335 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 4 62,066,044 - 62,944,053 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 4 62,045,434 - 62,620,763 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 4 62,191,604 - 62,766,933 NCBI Celera 4 59,821,669 - 60,396,265 (+) NCBI Celera Cytogenetic Map 4 q13.1 NCBI HuRef 4 58,271,407 - 58,846,164 (+) NCBI HuRef CHM1_1 4 62,398,708 - 62,974,117 (+) NCBI CHM1_1 T2T-CHM13v2.0 4 64,638,264 - 65,515,643 (+) NCBI T2T-CHM13v2.0
Adgrl3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 81,167,600 - 81,980,556 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 81,167,985 - 81,972,980 (+) Ensembl GRCm39 Ensembl GRCm38 5 81,019,085 - 81,827,825 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 81,020,138 - 81,825,133 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 81,450,618 - 82,224,755 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 82,096,154 - 82,870,291 (+) NCBI MGSCv36 mm8 Celera 5 78,280,126 - 79,039,754 (+) NCBI Celera Cytogenetic Map 5 D- E1 NCBI cM Map 5 42.62 NCBI
Adgrl3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955447 9,943,598 - 10,709,008 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955447 9,912,679 - 10,708,743 (-) NCBI ChiLan1.0 ChiLan1.0
ADGRL3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 3 67,717,238 - 68,578,490 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 4 67,937,970 - 68,799,235 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 4 61,876,694 - 62,742,354 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 4 68,315,996 - 69,183,881 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 4 68,323,404 - 69,003,093 (-) Ensembl panpan1.1 panPan2
ADGRL3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 13 52,742,043 - 53,568,184 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 13 52,909,684 - 53,538,625 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 13 52,651,031 - 53,476,080 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 13 53,378,322 - 54,210,364 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 13 53,378,109 - 54,181,953 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 13 53,058,300 - 53,887,839 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 13 52,577,693 - 53,373,845 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 13 53,501,337 - 54,367,460 (+) NCBI UU_Cfam_GSD_1.0
Adgrl3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405285 22,750,332 - 23,528,212 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936582 5,338,982 - 5,819,018 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936582 5,313,215 - 6,091,351 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ADGRL3 (Sus scrofa - pig)
ADGRL3 (Chlorocebus sabaeus - green monkey)
Adgrl3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 317 Count of miRNA genes: 180 Interacting mature miRNAs: 210 Transcripts: ENSRNOT00000044659, ENSRNOT00000048175, ENSRNOT00000059942 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1581500 Renag1 Renal agenesis QTL 1 kidney development trait (VT:0000527) percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) 14 8170668 68298175 Rat 731183 Pia20 Pristane induced arthritis QTL 20 3.55 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 14 9088978 39057237 Rat 631212 Bw5 Body weight QTL5 5.43 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 14 11030812 30320092 Rat 2302277 Gluco38 Glucose level QTL 38 5.8 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 11030622 28035204 Rat 10755459 Coatc15 Coat color QTL 15 0.01681 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 14 19836944 64836944 Rat 1331740 Bw26 Body weight QTL 26 3.028 body mass (VT:0001259) body weight (CMO:0000012) 14 3813074 30767156 Rat 619619 Rf4 Renal disease susceptibility QTL 4 4.1 0.002 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 14 1 32754612 Rat 1358296 Ael3 Aortic elastin QTL 3 3.7 0.00051 aorta elastin amount (VT:0003905) aortic elastin 14 8267090 53267090 Rat 71117 Niddm17 Non-insulin dependent diabetes mellitus QTL 17 2.35 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 14 17593761 42336881 Rat 61420 Pia6 Pristane induced arthritis QTL 6 4.9 joint integrity trait (VT:0010548) arthritic paw count (CMO:0001460) 14 18631345 42337007 Rat 7387267 Uae42 Urinary albumin excretion QTL 42 0.61 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 14 22167967 67167967 Rat 2300183 Bmd60 Bone mineral density QTL 60 5.7 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 14 1 26541967 Rat 631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 3.37 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 14 11030622 95876975 Rat 2313397 Coatc1 Coat color QTL1 coat/hair pigmentation trait (VT:0010463) coat/hair color measurement (CMO:0001808) 14 18541332 63541332 Rat 631262 Tcas4 Tongue tumor susceptibility QTL 4 7.29 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 14 17622561 42337007 Rat 634352 Apr6 Acute phase response QTL 6 3.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 14 1 41131407 Rat 2300159 Bmd61 Bone mineral density QTL 61 5.3 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 14 1 26541967 Rat 2302045 Pia39 Pristane induced arthritis QTL 39 4.9 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G2a level (CMO:0002116) 14 8267090 53267090 Rat 1300140 Srn3 Serum renin concentration QTL 3 3.19 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 14 14875168 30883947 Rat
D14Rat41
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 14 26,939,759 - 26,939,895 (+) Marker Load Pipeline mRatBN7.2 14 26,585,205 - 26,585,343 (+) MAPPER mRatBN7.2 Rnor_6.0 14 28,610,223 - 28,610,358 NCBI Rnor6.0 Rnor_5.0 14 28,430,315 - 28,430,450 UniSTS Rnor5.0 RGSC_v3.4 14 28,613,332 - 28,613,468 RGD RGSC3.4 RGSC_v3.4 14 28,613,333 - 28,613,468 UniSTS RGSC3.4 RGSC_v3.1 14 28,613,272 - 28,613,579 RGD Celera 14 25,946,331 - 25,946,466 UniSTS SHRSP x BN Map 14 15.94 RGD SHRSP x BN Map 14 15.94 UniSTS FHH x ACI Map 14 26.22 RGD Cytogenetic Map 14 p21 UniSTS
RH131601
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 26,632,977 - 26,633,164 (+) MAPPER mRatBN7.2 Rnor_6.0 14 28,660,581 - 28,660,767 NCBI Rnor6.0 Rnor_5.0 14 28,478,328 - 28,478,514 UniSTS Rnor5.0 RGSC_v3.4 14 28,661,008 - 28,661,194 UniSTS RGSC3.4 Celera 14 25,994,511 - 25,994,697 UniSTS RH 3.4 Map 14 337.9 UniSTS Cytogenetic Map 14 p21 UniSTS
RH144064
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 26,374,479 - 26,374,617 (+) MAPPER mRatBN7.2 Rnor_6.0 14 28,398,820 - 28,398,957 NCBI Rnor6.0 Rnor_5.0 14 28,220,371 - 28,220,508 UniSTS Rnor5.0 RGSC_v3.4 14 28,391,019 - 28,391,156 UniSTS RGSC3.4 RGSC_v3.4 14 28,316,659 - 28,316,796 UniSTS RGSC3.4 Celera 14 25,737,358 - 25,737,495 UniSTS RH 3.4 Map 14 338.4 UniSTS Cytogenetic Map 14 p21 UniSTS
BF397398
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 26,582,800 - 26,582,934 (+) MAPPER mRatBN7.2 Rnor_6.0 14 28,607,818 - 28,607,951 NCBI Rnor6.0 Rnor_5.0 14 28,427,910 - 28,428,043 UniSTS Rnor5.0 RGSC_v3.4 14 28,610,928 - 28,611,061 UniSTS RGSC3.4 Celera 14 25,943,926 - 25,944,059 UniSTS RH 3.4 Map 14 336.8 UniSTS Cytogenetic Map 14 p21 UniSTS
BE107836
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 14 26,574,328 - 26,574,479 (+) MAPPER mRatBN7.2 Rnor_6.0 14 28,599,348 - 28,599,498 NCBI Rnor6.0 Rnor_5.0 14 28,419,440 - 28,419,590 UniSTS Rnor5.0 RGSC_v3.4 14 28,602,458 - 28,602,608 UniSTS RGSC3.4 RH 3.4 Map 14 340.3 UniSTS Cytogenetic Map 14 p21 UniSTS
This gene Adgrl3 is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000044659 ⟹ ENSRNOP00000045365
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,223 - 27,105,860 (-) Ensembl Rnor_6.0 Ensembl 14 28,393,563 - 28,856,214 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000048175 ⟹ ENSRNOP00000039467
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,054 - 27,105,860 (-) Ensembl Rnor_6.0 Ensembl 14 28,394,103 - 28,967,980 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000059942 ⟹ ENSRNOP00000056687
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,054 - 27,105,860 (-) Ensembl Rnor_6.0 Ensembl 14 28,393,394 - 28,536,260 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000100277 ⟹ ENSRNOP00000096360
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,368,584 - 27,105,860 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000103416 ⟹ ENSRNOP00000084026
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,054 - 27,105,860 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000106702 ⟹ ENSRNOP00000092249
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,368,277 - 27,105,860 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112088 ⟹ ENSRNOP00000083229
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,054 - 27,105,860 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112583 ⟹ ENSRNOP00000076473
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,369,054 - 27,105,860 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112920 ⟹ ENSRNOP00000079850
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 14 26,368,277 - 27,105,860 (-) Ensembl
RefSeq Acc Id:
NM_130822 ⟹ NP_570835
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,722,194 - 27,458,104 (-) NCBI mRatBN7.2 14 26,367,629 - 27,103,586 (-) NCBI Rnor_6.0 14 28,392,913 - 28,856,315 (-) NCBI Rnor_5.0 14 28,183,727 - 29,040,121 (-) NCBI RGSC_v3.4 14 28,385,112 - 28,854,677 (-) RGD Celera 14 25,731,451 - 26,185,004 (-) RGD
Sequence:
AATCATTGATATTGGAATACAGAAGAGGAGCCAGAAGTATACTGATTTGGCTTCACCTCAGAACAGCCATTCTTGAGGCATTCTCCTCCGAGAACACAGCCATGTGTCCACCTCAGCTGTTCATCCTC ATGATGCTTTTAGCACCTGTAGTTCATGGTGGCAAGCACAATGAGAGACATCCAGCCCTCGCTGCTCCACTGCGACATGCTGAGCACAGCCCAGGAGGCCCTCTCCCTCCCAGACATCTTCTTCAGCA GCCAGCTGCAGAGCGCTCTACAGCTCATCGAGGACAAGGGCCACGTGGAACTGCCAGAGGAGTTCGCGGACCCGGTGCCCCAGGAGCACAGATTGCAGCCCAAGCTTTCAGCCGTGCCCCAATTCCCA TGGCAGTGGTCCGCAGAGAGCTCTCCTGTGAGAGCTACCCCATTGAGCTACGCTGTCCAGGCACAGACGTCATCATGATCGAAAGCGCCAACTACGGGAGGACAGATGACAAGATCTGTGACTCGGAC CCTGCTCAGATGGAGAATATTCGGTGTTATCTGCCAGATGCCTATAAGATTATGTCTCAAAGATGCAATAACAGAACCCAGTGTGCAGTGGTGGCAGGTCCTGATGTATTTCCAGACCCATGTCCGGG AACATATAAATACCTTGAAGTGCAGTATGAATGTGTCCCTTACAAAGTGGAACAAAAAGTTTTTCTTTGTCCCGGACTGCTCAAAGGAGTGTACCAGAGCGAACACTTGTTTGAATCTGACCACCAAT CTGGGGCATGGTGCAAAGACCCTCTACAGGCTTCTGACAAGATTTACTATATGCCCTGGACTCCCTACAGAACCGATACCCTGACAGAGTATTCATCCAAAGATGACTTCATTGCTGGAAGGCCGACA ACTACATACAAGCTCCCTCACAGAGTGGATGGTACTGGATTTGTAGTATATGATGGTGCCCTGTTCTTCAACAAGGAGCGTACAAGGAACATAGTAAAGTTTGATTTGAGGACTAGGATAAAGAGTGG AGAGGCAATCATAGCAAATGCTAACTACCATGATACCTCCCCATACCGATGGGGTGGCAAGTCCGACATAGACTTGGCAGTGGATGAAAACGGATTATGGGTAATCTATGCAACAGAACAGAACAATG GCAAAATTGTTATTAGCCAGTTGAACCCTTACACCCTACGGATTGAGGGGACATGGGACACTGCCTATGATAAAAGGTCTGCTTCCAATGCATTTATGATTTGTGGGATTCTGTATGTGGTCAAGTCT GTATATGAGGATGACGACAATGAGGCCACCGGTAATAAGATTGACTACATTTACAATACTGACCAAAGCAAGGATAGCCTGGTGGATGTACCCTTTCCCAACTCATACCAGTACATAGCAGCCGTGGA CTACAATCCCAGGGACAATCTGCTGTACGTGTGGAACAACTACCATGTTGTCAAATACTCCTTGGACTTCGGGCCTCTGGATAGCAGATCAGGGCCAGTGCATCATGGACAAGTTTCCTACATCTCTC CACCGATTCACCTTGACTCTGACCTGGAAAGGCCCCCTGTCAGAGGGATTTCTACCACAGGACCCCTGGGTATGGGAAGCACGACCACCAGCACCACCCTCCGGACTACCACCTGGAACCTAGGGAGG AGTACAACGCCATCCTTGCCTGGCAGAAGAAACCGCAGTACCAGTACGCCGTCCCCAGCGATTGAGGTGCTGGATGTTACCACACACCTGCCATCTGCAGCCTCCCAAATCCCAGCGATGGAAGAGAG CTGCGAGGCTGTGGAAGCCCGAGAGATCATGTGGTTTAAGACCCGACAGGGGCAAGTAGCAAAGCAGTCATGCCCAGCAGGAACCATAGGTGTATCAACTTACCTGTGTCTTGCTCCTGATGGAATAT GGGATCCCCAAGGACCAGATCTCAGCAACTGCTCTTCTCCTTGGGTCAATCACATAACACAGAAGCTGAAATCTGGAGAAACAGCTGCCAATATTGCCAGAGAGCTAGCAGAACAGACCAGAAATCAT TTGAACGCCGGGGATATCACCTACTCAGTTCGTGCCATGGACCAACTGGTTGGCCTCCTGGACGTACAGCTCAGGAATTTGACACCAGGGGGGAAGGACAGTGCTGCCCGAAGCTTGAACAAGCTTCA GAAAAGAGAGCGCTCTTGCAGAGCCTATGTCCAGGCGATGGTGGAGACAGTTAACAATCTCCTTCAGCCACAAGCTCTGAATGCGTGGAGGGACCTGACGACAAGTGATCAACTACGCGCAGCCACCA TGTTGCTCGACACTGTGGAGGAGAGTGCTTTCGTGTTAGCCGATAACCTTTTGAAGACCGACATTGTCAGGGAGAATACAGACAATATTCAGTTGGAGGTTGCAAGGCTGAGCACGGAAGGAAACCTA GAAGATCTAAAATTTCCAGAAAACACGGGCCACGGAAGCACTATACAGCTTTCCGCAAACACGTTAAAGCAAAATGGCCGGAATGGAGAGATTAGAGTGGCCTTTGTCCTGTATAACAACCTGGGTCC TTATTTATCTACGGAGAATGCCAGTATGAAGTTGGGCACAGAAGCTATGTCCACAAATCACTCAGTTATCGTCAATTCCCCTGTTATTACAGCAGCAATAAATAAGGAATTCAGTAATAAAGTGTATT TGGCTGATCCTGTGGTATTTACTGTTAAACATATCAAGCAGTCAGAGGAAAATTTCAACCCTAACTGTTCATTTTGGAGCTATTCCAAGCGCACAATGACAGGTTATTGGTCAACACAAGGCTGTCGA CTCCTGACAACGAACAAGACACACACTACGTGCTCCTGTAACCACCTCACCAACTTCGCAGTATTAATGGCACATGTGGAAGTTAAGCACAGCGATGCCGTCCACGATCTTCTTCTGGATGTGATCAC GTGGGTCGGAATCCTGTTGTCTCTTGTTTGTCTCCTGATCTGCATCTTCACATTCTGCTTCTTCCGTGGGCTTCAGAGCGACCGTAACACCATTCACAAGAACCTGTGCATCAGCCTGTTTGTGGCAG AACTGCTCTTCCTGATTGGGATCAACAGAACCGACCAACCGATTGCCTGTGCAGTGTTTGCGGCTCTTTTGCATTTCTTCTTCTTGGCGGCCTTCACCTGGATGTTTCTAGAAGGGGTACAGCTGTAT ATCATGCTGGTGGAGGTCTTTGAGAGTGAGCATTCCCGTAGGAAGTACTTCTATCTGGTTGGCTACGGGATGCCCGCACTCATCGTGGCCGTTTCTGCTGCAGTCGACTACAGGAGCTATGGAACAGA CAAAGTATGTTGGCTTCGCCTTGACACCTACTTCATTTGGAGTTTTATAGGACCAGCGACCTTGATAATTATGCTGAATGTAATCTTCCTCGGGATTGCTTTATACAAAATGTTTCACCATACTGCCA TACTGAAACCTGAATCAGGCTGTCTTGATAATATCAACTATGAGGATAACAGACCCTTCATCAAGTCATGGGTTATAGGTGCAATAGCGCTGCTCTGCCTATTAGGATTGACCTGGGCCTTTGGACTC ATGTATATTAATGAAAGCACAGTCATCATGGCGTATCTCTTCACCATTTTCAATTCTCTACAGGGGATGTTTATATTCATTTTCCACTGTGTCCTACAGAAGAAGGTACGGAAAGAGTATGGGAAATG CCTACGGACGCATTGCTGTAGTGGGAAAAGCACGGAGAGTTCGATTGGCTCAGGGAAAACATCTGGTTCTCGAACTCCAGGACGGTATTCCACAGGCTCACAGAGCCGGATTCGGAGAATGTGGAATG ACACCGTCCGAAAGCAGTCAGAGTCATCCTTCATCACTGGAGACATAAACAGCTCAGCGTCGCTCAACAGAGGATCCTATCTTCCCTGCATTCAGGCGTGTGTAACATATTTAGAGGGGCTTCTGAAC AATGCCAGGGATACAAGTGTCATGGATACTCTACCACTGAATGGTAACCATGGCAACAGTTACAGCATTGCTGGCGGCGAATACCTGAGCAACTGTGTGCAAATTATAGACCGTGGCTATAACCACAA CGAGACCGCCCTAGAAAAAAAGATCCTAAAGGAACTCACTTCCAACTATATCCCTTCATACCTGAACAACCACGAGCGCTCCAGCGAACAGAACCGGAACATGATGAACAAACTGGTGGACAACTTAG GCAGTGGGAGTGAAGATGACGCCATAGTCCTGGATGACGCAGCGTCCTTTAACCACGAGGAGAGTCTGGGCCTGGAACTCATTCACGAGGAATCGGATGCTCCCTTGCTGCCCCCGAGGGTTTACTCC ACCGATAACCACCAGCCACACCATTACAGCAGGAGGCGGCTCCCCCAGGACCACAGCGAGAGCTTCTTCCCTCTGCTAACCGACGAGCACACAGAAGACCCGCAGTCACCGCACAGGGACTCTCTGTA CACCAGCATGCCGGCCCTGGCCGGTGTGCCCGCTGCAGACAGTGTGACCACCAGCACCCAGACCGAAGCCGCAGCGGCCAAGGGTGGTGACGCCGAAGATGTTTACTACAAAAGCATGCCAAACCTGG GCTCCAGAAACCATGTGCACCCGCTGCACGCCTACTACCAGCTAGGGCGAGGCAGCAGCGATGGATTCATAGTTCCTCCCAATAAAGATGGGGCCTCTCCGGAGGGGACTTCCAAAGGACCGGCGCAC TTGGTCACTAGTCTATAGAAGGTGACACGGGGATGACAACCAACGGGACAGCTAACACCCGGTGGCCCATTCTGAGTCGATATAAGCAGTGGTCATCGTGTGTAACACGTGTGTGACATCTGATGCTG ATCTCAAAAGAGAGACTCTGACATTTGGTTTTTTTTTTTTTTTTTTAACTTGAATTTTTAGGTCAGCGCAGGGGAGAAAGCTCCCCCTGTGCCCCAGTCTTTCCCGTCTTTCCCCTCAGATGGACACT TCATTATGTTAATGAACGAGATAAGATGAAAATGGCGCTCATTGTGGCCCTGTTGAGTTAGGTTGTGATTAACAGCTCTGATGCTCTGTTACTAGAATCACGAGGACCTGATTTTTCTTTCTTTTTTT TTTTTTTAAAAAAAAAGAGGCCGGAACTATTGTTTGGAATTAGTAACAATGCTGCATCTAGATTGGAGTGCTGCCCAGCCGTAGAAGCAGAGCAGAACTGTATCCCATANCGGTGCGCGGTCACTCGC AACCTGAGTTCACCACAGCGAGCATAGCTGTGAAAAGCAAAAGCAAAACAACAGAATTAATAATCTGACGGTGGGGAATTCTAGAATTATATGCTAAATGCATATTTTATGATTTGCTGTATTAACTG ATGATAAAACTAATGGCAGAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_008769970 ⟹ XP_008768192
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,367,627 - 27,104,059 (-) NCBI Rnor_6.0 14 28,386,354 - 29,226,085 (-) NCBI
Sequence:
CTTCTTCTTTTTTTTTTTTTTTTTTTGCCCCGGGGCTCAATGGATGGATTGTGGAAAACTGCAC CGGGTTGCAGGTTGTTGAGCAACTGATGGGACCATCTCAGGGACCAGCGGTTACGAAAGATGCTGATTTGAAGAACTGCCCTGAAAACTGAAATGATTAATGCAGAAAGTCAGAAGACAGAACTATGG ATTTTTAGCAATCACAGAACAAATTAAGGTGTCTGACTTGGGAAATCAGTGTTTATTTTTGAGGAATTTTTCTTTCTTTCCTTTTTTTTTTTTGCTTTTGGTTTTTAATCATTGATATTGGAATACAG AAGAGGAGCCAGAAGTATACTGATTTGGCTTCACCTCAGAACAGCCATTCTTGAGGCATTCTCCTCCGAGAACACAGCCATGTGTCCACCTCAGCTGTTCATCCTCATGATGCTTTTAGCACCTGTAG TTCATGGTGGCAAGCACAATGAGAGACATCCAGCCCTCGCTGCTCCACTGCGACATGCTGAGCACAGCCCAGGAGGCCCTCTCCCTCCCAGACATCTTCTTCAGCAGCCAGCTGCAGAGCGCTCTACA GCTCATCGAGGACAAGGGCCACGTGGAACTGCCAGAGGAGTTCGCGGACCCGGTGCCCCAGGAGCACAGATTGCAGCCCAAGCTTTCAGCCGCGCCCCAATTCCCATGGCAGTGGTCCGCAGAGAGCT CTCCTGTGAGAGCTACCCCATTGAGCTACGCTGTCCAGGCACAGACGTCATCATGATCGAGAGCGCCAACTACGGGAGGACAGATGACAAGATCTGTGACTCGGACCCTGCTCAGATGGAGAATATTC GGTGTTATCTGCCAGATGCCTATAAGATTATGTCTCAAAGATGCAATAACAGAACCCAGTGTGCAGTGGTGGCAGGTCCTGATGTATTTCCAGACCCATGTCCGGGAACATATAAATACCTTGAAGTG CAGTATGAATGTGTCCCTTACAAAGTGGAACAAAAAGTTTTTCTTTGTCCCGGACTGCTCAAAGGAGTGTACCAGAGCGAACACTTGTTTGAATCTGACCACCAATCTGGGGCATGGTGCAAAGACCC TCTACAGGCTTCTGACAAGATTTACTATATGCCCTGGACTCCCTACAGAACCGATACCCTGACAGAGTATTCATCCAAAGATGACTTCATTGCTGGAAGGCCGACAACTACATACAAGCTCCCTCACA GAGTGGATGGTACTGGATTTGTAGTATATGATGGTGCCCTGTTCTTCAACAAGGAGCGTACAAGGAACATAGTAAAGTTTGATTTGAGGACTAGGATAAAGAGTGGAGAGGCAATCATAGCAAATGCT AACTACCATGATACCTCCCCATACCGATGGGGTGGCAAGTCCGACATAGACTTGGCAGTGGATGAAAACGGATTATGGGTAATCTATGCAACAGAACAGAACAATGGCAAAATTGTTATTAGCCAGTT GAACCCTTACACCCTACGGATTGAGGGGACATGGGACACTGCCTATGATAAAAGGTCTGCTTCCAATGCATTTATGATTTGTGGGATTCTGTATGTGGTCAAGTCTGTATATGAGGATGACGACAATG AGGCCACCGGTAATAAGATTGACTACATTTACAATACTGACCAAAGCAAGGATAGCCTGGTGGATGTACCCTTTCCCAACTCATACCAGTACATAGCAGCCGTGGACTACAATCCCAGGGACAATCTG CTGTACGTGTGGAACAACTACCATGTTGTCAAATACTCCTTGGACTTCGGGCCTCTGGATAGCAGATCAGGGCCAGTGCATCATGGACAAGTTTCCTACATCTCTCCACCGATTCACCTTGACTCTGA CCTGGAAAGGCCCCCTGTCAGAGGGATTTCTACCACAGGACCCCTGGGTATGGGAAGCACGACCACCAGCACCACCCTCCGGACTACCACCTGGAACCTAGGGAGGAGTACAACGCCATCCTTGCCTG GCAGAAGAAACCGCAGTACCAGTACGCCGTCCCCAGCGATTGAGGTGCTGGATGTTACCACACACCTGCCATCTGCAGCCTCCCAAATCCCAGCGATGGAAGAGAGCTGCGAGGCTGTGGAAGCCCGA GAGATCATGTGGTTTAAGACCCGACAGGGGCAAGTAGCAAAGCAGCCATGCCCAGCAGGAACCATAGGTGTATCAACTTACCTGTGTCTTGCTCCTGATGGAATATGGGATCCCCAAGGACCAGATCT CAGCAACTGCTCTTCTCCTTGGGTCAATCACATAACACAGAAGCTGAAATCTGGAGAAACAGCTGCCAATATTGCCAGAGAGCTAGCAGAACAGACCAGAAATCATTTGAACGCCGGGGATATCACCT ACTCAGTTCGTGCCATGGACCAACTGGTTGGCCTCCTGGACGTACAGCTCAGGAATTTGACACCAGGGGGGAAAGACAGTGCTGCCCGAAGCTTGAACAAGCTTCAGAAAAGAGAGCGCTCTTGCAGA GCCTATGTCCAGGCGATGGTGGAGACAGTTAACAATCTCCTTCAGCCACAAGCTCTGAATGCGTGGAGGGACCTGACGACAAGTGATCAACTACGCGCAGCCACCATGTTGCTCGACACTGTGGAGGA GAGTGCTTTCGTGTTAGCCGATAACCTTTTGAAGACCGACATTGTCAGGGAGAATACAGACAATATTCAGTTGGAGGTTGCAAGGCTGAGCACGGAAGGAAACCTAGAAGATCTAAAATTTCCAGAAA ACACGGGCCACGGAAGCACTATACAGCTTTCCGCAAACACGTTAAAGCAAAATGGCCGGAATGGAGAGATTAGAGTGGCCTTTGTCCTGTATAACAACCTGGGTCCTTATTTATCTACGGAGAATGCC AGTATGAAGTTGGGCACAGAAGCTATGTCCACAAATCACTCAGTTATCGTCAATTCCCCTGTTATTACAGCAGCAATAAATAAGGAATTCAGTAATAAAGTGTATTTGGCTGATCCTGTGGTATTTAC TGTTAAACATATCAAGCAGTCAGAGGAAAATTTCAACCCTAACTGTTCATTTTGGAGCTATTCCAAGCGCACAATGACAGGTTATTGGTCAACACAAGGCTGTCGACTCCTGACAACGAACAAGACAC ACACTACGTGCTCCTGTAACCACCTCACCAACTTCGCAGTATTAATGGCACATGTGGAAGTTAAGCACAGCGATGCCGTCCACGATCTTCTTCTGGATGTGATCACGTGGGTCGGAATCCTGTTGTCT CTTGTTTGTCTCCTGATCTGCATCTTCACATTCTGCTTCTTCCGTGGGCTCCAGAGCGACCGTAACACCATTCACAAGAACCTGTGCATCAGCCTGTTTGTGGCAGAACTGCTCTTCCTGATTGGGAT CAACAGAACCGACCAACCGATTGCCTGTGCAGTGTTTGCGGCTCTTTTGCATTTCTTCTTCTTGGCGGCCTTCACCTGGATGTTTCTAGAAGGGGTACAGCTGTATATCATGCTGGTGGAGGTCTTTG AGAGTGAGCATTCCCGTAGGAAGTACTTCTATCTGGTTGGCTACGGGATGCCCGCACTCATCGTGGCCGTTTCTGCTGCAGTCGACTACAGGAGCTATGGAACAGACAAAGTATGTTGGCTTCGCCTT GACACCTACTTCATTTGGAGTTTTATAGGACCAGCGACCTTGATAATTATGCTGAATGTAATCTTCCTCGGGATTGCTTTATACAAAATGTTTCACCATACTGCCATACTGAAACCTGAATCAGGCTG TCTTGATAATATCAACTATGAGGATAACAGACCCTTCATCAAGTCATGGGTTATAGGTGCAATAGCGCTGCTCTGCCTATTAGGATTGACCTGGGCCTTTGGACTCATGTATATTAATGAAAGCACAG TCATCATGGCGTATCTCTTCACCATTTTCAATTCTCTACAGGGGATGTTTATATTCATTTTCCACTGTGTCCTACAGAAGAAGGTACGGAAAGAGTATGGGAAATGCCTACGGACGCATTGCTGTAGT GGGAAAAGCACGGAGAGTTCGATTGGCTCAGGGAAAACATCTGGTTCTCGAACTCCAGGACGGTATTCCACAGGCTCACAGAGCCGGATTCGGAGAATGTGGAATGACACCGTCCGAAAGCAGTCAGA GTCATCCTTCATCACTGGAGACATAAACAGCTCAGCGTCGCTCAACAGAGGAACCATGGCTAATCATCTTATGAGCAATGCTCTTCTTCGTCCGCATGGTACTAACAATCCCTATAACACATTGCTTG GGGAACCGGCGGTCTGTAACAACCCTTCTATCAGCATGTACAACGCACAAGAGGGGCTTCTGAACAATGCCAGGGATACAAGTGTCATGGATACTCTACCACTGAATGGTAACCATGGCAACAGTTAC AGCATTGCTGGCGGCGAATACCTGAGCAACTGTGTGCAAATTATAGACCGTGGCTATAACCACAACGAGACCGCCCTAGAGAAAAAGATCCTAAAGGAACTCACTTCCAACTATATCCCTTCATACCT GAACAACCACGAGCGCTCCAGCGAACAGAACCGGAACATGATGAACAAACTGGTGGACAACTTAGGCAGTGGGAGTGAAGATGACGCCATAGTCCTGGATGACGCAGCGTCCTTTAACCACGAGGAGA GTCTGGGCCTGGAACTCATTCACGAGGAATCGGATGCTCCCTTGCTGCCCCCGAGGGTTTACTCCACCGATAACCACCAGCCACACCATTACAGCAGGAGGCGGCTCCCCCAGGACCACAGCGAGAGC TTCTTCCCTCTGCTAACCGACGAGCACACAGAAGACCCGCAGTCACCGCACAGGGACTCTCTGTACACCAGCATGCCGGCCCTGGCCGGTGTGCCCGCTGCAGACAGTGTGACCACCAGCACCCAGAC CGAAGCCGCAGCGGCCAAGGGTGGTGACGCCGAAGATGTTTACTACAAAAGCATGCCAAACCTGGGCTCCAGAAACCATGTGCACCCGCTGCACGCCTACTACCAGCTAGGGCGAGGCAGCAGCGATG GATTCATAGTTCCTCCCAATAAAGATGGGGCCTCTCCGGAGGGGACTTCCAAAGGACCGGCGCACTTGGTCACTAGTCTATAGAAGGTGACACGGGGATGACAACCAACGGGACAGCTAACACCCGGT GGCCCATTCTGAGTCGATATAAGCAGTGGTCATCGTGTGTAACACGTGTGTGACATCTGATGCTGTTCTCAAAAGAGAGACTCTGACATTTGGTTTTTTTTTTTTTTTTTTAACTTGAATTTTTAGGT CAGCGCAGGGGAGAAAGCTCCCCCTGTGCCCCAGTCTTTCCCGTCTTTCCCCTCAGATGGACACTTCATTATGTTAATGAACGAGATAAGATGAAAATGGCGCTCATTGTGGCCTTGTTGAGTTAGGT TGTGATTAACAGCTCTGATGCTCTGTTACTAGAATCACGAGGACCTGATTTTTCTTTCTTTTTTTTTTTTTAAAAAAAAAAGAGGCCGGAACTATTGTTTGGAATTAGTAACAATGCTGCATCTAGAT TGGAGTGCTGCCCAGCCGTAGAAGCAGAGCAGAACTGTATCCCATAGCGGTGCGCGGTCACTCGCAACCTGAGTTCACCACAGCGAGCATAGCTGTGAAAAGCAAAAGCAAAACAACAGAATTAATAA TCTGACGGTGGGGAATTCTAGAATTATATGCTAAATGCATATTTTATGATTTGCTGTATTAACTGATGATAAAACTAATGGCAGAAAAAAAAAGAATTGAACAATTTCTATGTCATGTACAGATACTA GCATTGCGCATATAGTCTGCTTTTTGTTCCTCCAGAATTTGAGTCCTGTTAATGTAGTGGCAAAGAAGAAATTTTCCTTTTCTTTTGTGCTAGTCTTGCAAGTTTGTCTACCAGTAAAAGAGCAAAGT TTCCTTCCTTTCTTGTTTTCTTTCTTTTTATTTGTTCTTTTGTCCCCTCTCCCCCCACCCCACCTTTTTATTTTTCCTTTAAAAATTCACCTGGCAAAAAATAATAATAATAAATAAATAAATGAAGC TATCACTTTATAAGAATCATTTTCTAGTAATGCAAACAAATTATTTTTTAACAAAAAATAAAATAAAATAAATAAAATTAGACTTCCTTCCCTCCATATATATCTATCTATCTATATTTATCCAGCCC GAGTATTTCCAATGTCATTTTTGCAAATTAGAGCAGGACAAATTTTACATTTCCAGGGCACATCTGTTGTAATGCGAAGCATTATTTGGCAAGCAGTTCATCACCAAGGCAGTAGCTATGATTCTAGA AGCTAAGAGGTGTCTATAGAGCTAGAGGGGGCTTCTGCATGTGAAATGCTGTAATTCGTAGGCGTTAAAAGTGCTGAATGGGCAGTCTGACCCCCACGTGGGCACCTGCACTACCAATTGTTAGAGGA AATTCACTCCCTCCTAGTGAGAGTTGAAAGGTCAAATTATTTTGAGGTAATTCTTTTTTTTTAAAGTTTTCTGTTAACAGGAAAATTTATTTATTTGACAGGATTTTAAGTAATGTAGAGATACAAAT GGTAAATTAGCAGCACATATAATTTTTTTTAAATTTATGATCCATTTTGTATGGTCTCAAGTTGGATGACCTCATTACTAATATTTGTTGTAAAAGTGAAACTTGTTTGCCGACCAATAAACAACTGA TTGAGATTTAGAAGAGATGGCTTTGACGTATGTACTATATTATCAAGTCCTCTTTTGACTTTCCTTGCCTTTCCTTTTCTTTGTTTTCATAATATAAACTCTTCTTAACCTCTGTGACCCAAGTGAGC AACACACACACACACACACACACACACACACTCTCACACTCAGATATATATCTGACTTGAATATCCAAACACAACAGTACAGATTTTTGCAGACAAAGTTGATGCATAGCACCCACTCAAGTGGGATA AGGAAGATCACTCATCTCTAGTCACTAGGCTTAAGGCTAAAGACAGTCATCCAGTGGTTTAAATATCACTTGTGATGCGGCCATCTCTCAGGGCCCCTTATTGTAATCTTTATTCTAATGGAGGAATT TGGAAATTTAAATTTCCTCAGTTGGCTAAGAAGCACAATAGTAAAAGCAAAGACCTTATTCATTGTACCAGAAGAATATAAGGTCATTAACATCGACACACTGTGTTAGTTTTCTCTATGGCCACCTC AAACAAAATCTGTTGTGTTGGTTCTCCTCCATCCCTCTGACTCCCTTTCTGTAGTCTCTGACACCTCACCCTGCCCCAATGCATATTTCCCACCTTTATGCCTCCTATGTAAGACCTTTTTACTTTGT TTTTGTCTTCTTCAATGTATGGGTACTGGTGAAGGACAAAAGAATTCCTTCAAAAGAACTTTGTAGATCTTTCTATTCCTACACTACCAATGTGTCAGATCAAGGAGCCCCACGTAGAATAAAGCTCA AATGAACTTGCCAAAGTATATTTTCCCTTGTAGTATATCCTTGGGCTTACTTTACAAAAGCCCACGCACTAGCTATCTCTAAATGATATCTTAAATCAAGGTGAGAGGCGTTGAGAGTGTGACCAGCC AGTCTTCCATAGACACTGTAAAGTCTGTGGTAGAGAGGAAGTTGTGCACCCATTAATCTGAAAGTCATTTCAAAAGAATCCATGGATCATTTGATTTTAGCCAGATGATGGCAATATTTTCTTGAAAT CCATAAACATTTTAATTTGGAAGAGAAACATAAGCATTAGAAGTAATTAGTTTTCTCACGACATGGTTTGGGAATATTCCCCACATTACCGATAACCCACCCGATACCTATAAAAAAAATTCCCTCAG TGAGCAAACCTAAGTCAGCCTCAGAAATAAGGCTATTGTTTGTGGAGTGCTAACACTTGTGCTTGATTTAAAAAAATACTATCCCAAAGGAAAGCAATATCAGTAAAAGGCCGTTTCATGAGACAGTG GCGACCCTACTTCAGTCCAGCTCTTCAATCGTCTGTAATCTGGCATTACTACTTTCCTGTGTGGTGCTGTGTGTTTCGTTATCCAGAACTTGAAAGAGGTAGCCTTCCCATTTCTACCGGGAACAACC TGAAGAAAGATCACTTGAATACATCAACTGGTATCCAAGGCCTCTGCCTACTGTGCGCTAACGTTGCTCTTGCATCAAGACGAAAGGGCCATTGGCGACCTCTCCTCTCATACATCATAACTGCCGTG CTTCAGAGAGTTAATCCTGTGGGAATCAGACCAACATCATTTAAAAGGACAATTAATAGAATCAATATGCAGGGAGATCTTATACTATGCAACAGCAGAATGTTCTCCTCACCTTGAAAAACCTTTGC TATGCGACTCTAATTAAACAGAAGAAACAGTAGGTAACGTACGTGACTGTGTCTCATTTCAGTAGAAGTGTGTATATTCATTTAGTCCTGATTATACCACCTACATTATAGTTCCTGACCCTTGCTTC CACCCGACTTTTCATGCAAAGGCACTGACACATTAATGCTAATAACTTTTTCTTCATTCTAGAACCTTTGGTTGATTCTAAGTCTTCAGTACAGGGCGGCATTCGTTGCGTGCTTATTTGCATATTTT ACCAGAAGTAAATTTCTACCAAACAGACTCAGTGTGCATACATAGCACATTATTCAGCCCACTGAAAGAGAGAGAGTCATGTAAATGAAACAAGCCAATTATTGCTTTCTAGTAAATAATATTTTTGT AATATTTTACGCTTGAAGTTTTTACCTCTTTGAGGTCTTAAGTAATGAGATAATTTGTCAGGGCACTAACTTAAGGACCTCAGGTGTAATCGATTCTTGTATTGATGGCTTGTTGCATAGCCAATGAT GCTAATTGATAATATTTATAAGTAAATAGAAATTCAAAGCAGAAAATTGGTTGGAATTCAGTTAAATTGTGTGAACATCCCTCTTCGTTTTTAACACAGTAAATGTGAACATATGGGAGATAAATGTC GAAGCCCCGTGCTAGAATAATCTTAGTGAGTAAAATGAATTGGCCTGAGAACAATTATAACTATATTAAAATAAAAATAAGCAGCCAAAGCAAAGGCAGCTAATTAAGTTAATCATAATTTCTTATTA AAGAAGGCCCATGGTGGTTCTAAATTAAATCATAGTTTATGAAATGCTGTTTTTAAGACCACCTATACAATTTAAAAAATTGATGCACTAAAAATATCTTTTAAAAATTTGGGCTTTGAATTTTTTTT TTTTAATCGGAGCTGAGGACCGAACCCAGGGCCTTGAGCTTGTAGGCAAGCGCTCTACCACTGAGCTAAATCCCCAACCCAAATTTGGGCTTTGAATCTTCAGTGTCAACAGTGTGATGAATCCTCTG ACGTTAATGATAACTTTAAAACATGTTTGGAAGTAACTGTAGTTTTGTAGGAAAGGGGGAAAAGCTTTTGTCTAACAAACAATTGTTAGCGGAATTGTATCTATGCCATAGAAATGAAAGTCTTTAGT TTTTAAAGTTGTTCATTAACACTGTATAAAACTCCAGTACTTAACATATTTTGGAGGAAAACAAAAAAAAACACCAATAAAAACAACAAACAAACAAAAGTCACTTTAACATAAATGAATGTCAACTT AAAGAGTCAAAAATAATCTGAAATTCTTATCTGATAGGAATTGGTACATTAGCCATAGTCCTTTACTCCAAGACAAGTAATTGATATAAAATTCTATGTACAAACTTCTCAGTATATTATAGGCCAGA ATACAAATATTTAATTGTTTATTTTTAATATGTCATAATCTTTCACATAAACAATTACTATGCATTCCTAATTAGAATCTATATATTAGATCTTTCCATGTCAAATTTTAGAAAGAAGACAGAAGGAA CACAAATACATAGAAAAACAGGTTTGGGAAACATTTTCATATAAATGAATTCTATGTAAAAAAAAATTTTTTTAAGAGTTCATAAAATAGAGTCCAAAGACTAAACTCAGTTTTGCAATCAGGAAATT TGTCTGTTTTAAACCATCTGAAAAACATGTTTTTAGACATCTGAACTTTCATTTATAATCTAAAAGTGTTGATAGTTGGTATAGCTGTTTGTGTCCTGGTTAAGCCATAGGGGACATTTATCTAAGGC ATCCATTTACCTTGATGACGTCATGCTTGCTTTACAAAGGAAAATGGTCTTTAAATTGTCACCTGTATATGTGTTTGAACAGTCTAATTTTTAATAAGATTTCAGAGGAAGTAACTTTTTTACAATTA GCCAGGGAGTTAGTTTTGTATATTCTCATTTTAAGTAATCATTATAGTCTTCTAAAAAAATTATAATCATCAGTTTGCCTGTAGCACTTTTAAGTTGTTATTAAAAATGCCTCAATTCCAAATATGTT TTTGAACCTTTACCTGTCTTACCAGTATGTTGACTGTATTTTTCTTCATTTGTAATTTCCCTGCCACTGGAGAACATGATAAAAGGAATTGGGGACTGATTTATGTGACGATTAAGAAACAGCTCACG GACACCACCTTCTTTTAATCAGCTAGGAGTTTTAACTGTAGTCCGAACAGTTCCAATCAGAACCTGTTTGGCAAAGTTTTCCCAAATACACAATATCTACATTAGCATTTTAAAGGAAAGGTTTCAGG GGAAGGGGTGAAATTGCTTATAATGATTAAAAAGCTGTTGTGCCCAATACTTCTGATGTGTTAAGAAAAAAATGTAAATTCGTATATTTTCATCATTCTAAAACCACAGAAAATACAACATGCTGTTA GCCTTTTTTTTTTTATATTTCTCACGCGGTTAACTCCTGTTGCACAGAAATTTCAATACTTCCTAATTGTCTCTAAAATATAAGTATTTCTCATCAGTTCACCTTCACCCTCTGATCTCCTGACTATT GAATACCTACACACTTAATGCAACCCGTAGCTTTGTGATTTTTACAGCTTTATTATGACCCTCTCTAGTAAAATTGATATTAGAAGTATATGCATTGTGCAAAATAATTAACAACCTATAGTCTTATG ACAAAATAGCCAGGCACATATATACACACATATATATCTATACCTGAATATTGTTGACTTATCAAATTACCACCATGCTGACAGTTGTCGATCACGGTAGTCACTTCCCACAATTCTGCAAAGAACTC TACATATTCTAGACTATTGAAATACTTGACAATACAACGCATCAGAATGGATTCCCAGTGCATCTTGAGAACCCAATAGTTTTATATCGAAGTGCTACCTTTGAGCTAAGGAGGAAGGTGCAAAAAAA AATCTAATTAACAGAGGAATTTAGATTTGTTTTACTGGCCCAACACTGGAAAATTCTTACAACGTGAATCAGATATAGCTTCTTAACTGCATACAGATGACAAGGTAATGGTGTCAACCTTAAAAATT GCTTTGTTCCCACTGATGTTTGAAACAGGCACAATAATATTGCCACCCTTATTGATTGACTTCAAAAGATGTCTCATGGACCTAGAGAATCATGACACAGGGGAGCAGTGTGGTTCTTCAGAGTTGGG GCACAGTGGCTATAACAGTGTGGCCTTAATGCTGAAAGCTGATTATCATTGTACAGTCTTGCTTTCAATGCCTCAACTTTCAATTGTCCTAATGGCTGATGGTTTGATTGACATTTTGAATCACAAAG GACAAAGAAAATCACTGAATGCTGGCTTTCACACACCAGTGGAAAGTAAAGATATCCTATTCTATCCTGAATCATAAAAAATTGTGTTGTCCTGCAGAATTGTAGACAGCTGTGTGTGTGTGCGTGTG CTTTGTAGATATGTCTCCGTCATCTATGTATTCTAACACCAGTGTCAATATTCTAACATCTAATACTTCCTGTAAACTATAAATTCAAAAAAACTGTAGAACCAGATTTTTTTCTCCCTTGGCTTTTC TAAAGGCTTTGGAACAGGACAGATAACTGGGAAAGTTTTCCATATTGTATTTATTCTTGACAAAGATTCACATTTAATTCATGATATAAGTCTGTTAAAAATAGCTTATTTTGAAGACTAACAACTGA TCGAGCTACTCCTCACTGATATGAAAAATCACTTACAGAAGCAAATACATAGCTATTGTAACATTGGTCTCATAGAATTCTTCTATATTCACATATAACACTATTCTGGCCATACGCACTGATAAATT TCAAGGTACTCAACCCCCACTACCCTCTTGTACAATCCTTTTATCCTTTTTAAAAACTATGCTTTGTACAATCACGTGTAAAATCATGAGCTACAAAACTCAATAAAACATAAGTAAACAACCA
hide sequence
RefSeq Acc Id:
XM_017599059 ⟹ XP_017454548
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,367,627 - 27,104,059 (-) NCBI Rnor_6.0 14 28,386,354 - 29,226,085 (-) NCBI
Sequence:
CTTCTTCTTTTTTTTTTTTTTTTTTTGCCCCGGGGCTCAATGGATGGATTGTGGAAAACTGCACCGGGTTGCAGGTTGTTGAGCAACTGATGGGACCATCTCAGGGACCAGCGGTTACGAAAGATGCT GATTTGAAGAACTGCCCTGAAAACTGAAATGATTAATGCAGAAAGTCAGAAGACAGAACTATGGATTTTTAGCAATCACAGAACAAATTAAGGTGTCTGACTTGGGAAATCAGTGTTTATTTTTGAGG AATTTTTCTTTCTTTCCTTTTTTTTTTTTGCTTTTGGTTTTTAATCATTGATATTGGAATACAGAAGAGGAGCCAGAAGTATACTGATTTGGCTTCACCTCAGAACAGCCATTCTTGAGGCATTCTCC TCCGAGAACACAGCCATGTGTCCACCTCAGCTGTTCATCCTCATGATGCTTTTAGCACCTGTAGTTCATGGTGGCAAGCACAATGAGAGACATCCAGCCCTCGCTGCTCCACTGCGACATGCTGAGCA CAGCCCAGGAGGCCCTCTCCCTCCCAGACATCTTCTTCAGCAGCCAGCTGCAGAGCGCTCTACAGCTCATCGAGGACAAGGGCCACGTGGAACTGCCAGAGGAGTTCGCGGACCCGGTGCCCCAGGAG CACAGATTGCAGCCCAAGCTTTCAGCCGCGCCCCAATTCCCATGGCAGTGGTCCGCAGAGAGCTCTCCTGTGAGAGCTACCCCATTGAGCTACGCTGTCCAGGCACAGACGTCATCATGATCGAGAGC GCCAACTACGGGAGGACAGATGACAAGATCTGTGACTCGGACCCTGCTCAGATGGAGAATATTCGGTGTTATCTGCCAGATGCCTATAAGATTATGTCTCAAAGATGCAATAACAGAACCCAGTGTGC AGTGGTGGCAGGTCCTGATGTATTTCCAGACCCATGTCCGGGAACATATAAATACCTTGAAGTGCAGTATGAATGTGTCCCTTACATTTTTCTTTGTCCCGGACTGCTCAAAGGAGTGTACCAGAGCG AACACTTGTTTGAATCTGACCACCAATCTGGGGCATGGTGCAAAGACCCTCTACAGGCTTCTGACAAGATTTACTATATGCCCTGGACTCCCTACAGAACCGATACCCTGACAGAGTATTCATCCAAA GATGACTTCATTGCTGGAAGGCCGACAACTACATACAAGCTCCCTCACAGAGTGGATGGTACTGGATTTGTAGTATATGATGGTGCCCTGTTCTTCAACAAGGAGCGTACAAGGAACATAGTAAAGTT TGATTTGAGGACTAGGATAAAGAGTGGAGAGGCAATCATAGCAAATGCTAACTACCATGATACCTCCCCATACCGATGGGGTGGCAAGTCCGACATAGACTTGGCAGTGGATGAAAACGGATTATGGG TAATCTATGCAACAGAACAGAACAATGGCAAAATTGTTATTAGCCAGTTGAACCCTTACACCCTACGGATTGAGGGGACATGGGACACTGCCTATGATAAAAGGTCTGCTTCCAATGCATTTATGATT TGTGGGATTCTGTATGTGGTCAAGTCTGTATATGAGGATGACGACAATGAGGCCACCGGTAATAAGATTGACTACATTTACAATACTGACCAAAGCAAGGATAGCCTGGTGGATGTACCCTTTCCCAA CTCATACCAGTACATAGCAGCCGTGGACTACAATCCCAGGGACAATCTGCTGTACGTGTGGAACAACTACCATGTTGTCAAATACTCCTTGGACTTCGGGCCTCTGGATAGCAGATCAGGGCCAGTGC ATCATGGACAAGTTTCCTACATCTCTCCACCGATTCACCTTGACTCTGACCTGGAAAGGCCCCCTGTCAGAGGGATTTCTACCACAGGACCCCTGGGTATGGGAAGCACGACCACCAGCACCACCCTC CGGACTACCACCTGGAACCTAGGGAGGAGTACAACGCCATCCTTGCCTGGCAGAAGAAACCGCAGTACCAGTACGCCGTCCCCAGCGATTGAGGTGCTGGATGTTACCACACACCTGCCATCTGCAGC CTCCCAAATCCCAGCGATGGAAGAGAGCTGCGAGGCTGTGGAAGCCCGAGAGATCATGTGGTTTAAGACCCGACAGGGGCAAGTAGCAAAGCAGCCATGCCCAGCAGGAACCATAGGTGTATCAACTT ACCTGTGTCTTGCTCCTGATGGAATATGGGATCCCCAAGGACCAGATCTCAGCAACTGCTCTTCTCCTTGGGTCAATCACATAACACAGAAGCTGAAATCTGGAGAAACAGCTGCCAATATTGCCAGA GAGCTAGCAGAACAGACCAGAAATCATTTGAACGCCGGGGATATCACCTACTCAGTTCGTGCCATGGACCAACTGGTTGGCCTCCTGGACGTACAGCTCAGGAATTTGACACCAGGGGGGAAAGACAG TGCTGCCCGAAGCTTGAACAAGCTTCAGAAAAGAGAGCGCTCTTGCAGAGCCTATGTCCAGGCGATGGTGGAGACAGTTAACAATCTCCTTCAGCCACAAGCTCTGAATGCGTGGAGGGACCTGACGA CAAGTGATCAACTACGCGCAGCCACCATGTTGCTCGACACTGTGGAGGAGAGTGCTTTCGTGTTAGCCGATAACCTTTTGAAGACCGACATTGTCAGGGAGAATACAGACAATATTCAGTTGGAGGTT GCAAGGCTGAGCACGGAAGGAAACCTAGAAGATCTAAAATTTCCAGAAAACACGGGCCACGGAAGCACTATACAGCTTTCCGCAAACACGTTAAAGCAAAATGGCCGGAATGGAGAGATTAGAGTGGC CTTTGTCCTGTATAACAACCTGGGTCCTTATTTATCTACGGAGAATGCCAGTATGAAGTTGGGCACAGAAGCTATGTCCACAAATCACTCAGTTATCGTCAATTCCCCTGTTATTACAGCAGCAATAA ATAAGGAATTCAGTAATAAAGTGTATTTGGCTGATCCTGTGGTATTTACTGTTAAACATATCAAGCAGTCAGAGGAAAATTTCAACCCTAACTGTTCATTTTGGAGCTATTCCAAGCGCACAATGACA GGTTATTGGTCAACACAAGGCTGTCGACTCCTGACAACGAACAAGACACACACTACGTGCTCCTGTAACCACCTCACCAACTTCGCAGTATTAATGGCACATGTGGAAGTTAAGCACAGCGATGCCGT CCACGATCTTCTTCTGGATGTGATCACGTGGGTCGGAATCCTGTTGTCTCTTGTTTGTCTCCTGATCTGCATCTTCACATTCTGCTTCTTCCGTGGGCTCCAGAGCGACCGTAACACCATTCACAAGA ACCTGTGCATCAGCCTGTTTGTGGCAGAACTGCTCTTCCTGATTGGGATCAACAGAACCGACCAACCGATTGCCTGTGCAGTGTTTGCGGCTCTTTTGCATTTCTTCTTCTTGGCGGCCTTCACCTGG ATGTTTCTAGAAGGGGTACAGCTGTATATCATGCTGGTGGAGGTCTTTGAGAGTGAGCATTCCCGTAGGAAGTACTTCTATCTGGTTGGCTACGGGATGCCCGCACTCATCGTGGCCGTTTCTGCTGC AGTCGACTACAGGAGCTATGGAACAGACAAAGTATGTTGGCTTCGCCTTGACACCTACTTCATTTGGAGTTTTATAGGACCAGCGACCTTGATAATTATGCTGAATGTAATCTTCCTCGGGATTGCTT TATACAAAATGTTTCACCATACTGCCATACTGAAACCTGAATCAGGCTGTCTTGATAATATCAACTATGAGGATAACAGACCCTTCATCAAGTCATGGGTTATAGGTGCAATAGCGCTGCTCTGCCTA TTAGGATTGACCTGGGCCTTTGGACTCATGTATATTAATGAAAGCACAGTCATCATGGCGTATCTCTTCACCATTTTCAATTCTCTACAGGGGATGTTTATATTCATTTTCCACTGTGTCCTACAGAA GAAGGTACGGAAAGAGTATGGGAAATGCCTACGGACGCATTGCTGTAGTGGGAAAAGCACGGAGAGTTCGATTGGCTCAGGGAAAACATCTGGTTCTCGAACTCCAGGACGGTATTCCACAGGCTCAC AGAGCCGGATTCGGAGAATGTGGAATGACACCGTCCGAAAGCAGTCAGAGTCATCCTTCATCACTGGAGACATAAACAGCTCAGCGTCGCTCAACAGAGGAACCATGGCTAATCATCTTATGAGCAAT GCTCTTCTTCGTCCGCATGGTACTAACAATCCCTATAACACATTGCTTGGGGAACCGGCGGTCTGTAACAACCCTTCTATCAGCATGTACAACGCACAAGAGCCCTACAGAGAGACAAAGGGGCTTCT GAACAATGCCAGGGATACAAGTGTCATGGATACTCTACCACTGAATGGTAACCATGGCAACAGTTACAGCATTGCTGGCGGCGAATACCTGAGCAACTGTGTGCAAATTATAGACCGTGGCTATAACC ACAACGAGACCGCCCTAGAGAAAAAGATCCTAAAGGAACTCACTTCCAACTATATCCCTTCATACCTGAACAACCACGAGCGCTCCAGCGAACAGAACCGGAACATGATGAACAAACTGGTGGACAAC TTAGGCAGTGGGAGTGAAGATGACGCCATAGTCCTGGATGACGCAGCGTCCTTTAACCACGAGGAGAGTCTGGGCCTGGAACTCATTCACGAGGAATCGGATGCTCCCTTGCTGCCCCCGAGGGTTTA CTCCACCGATAACCACCAGCCACACCATTACAGCAGGAGGCGGCTCCCCCAGGACCACAGCGAGAGCTTCTTCCCTCTGCTAACCGACGAGCACACAGAAGACCCGCAGTCACCGCACAGGGACTCTC TGTACACCAGCATGCCGGCCCTGGCCGGTGTGCCCGCTGCAGACAGTGTGACCACCAGCACCCAGACCGAAGCCGCAGCGGCCAAGGGTGGTGACGCCGAAGATGTTTACTACAAAAGCATGCCAAAC CTGGGCTCCAGAAACCATGTGCACCCGCTGCACGCCTACTACCAGCTAGGGCGAGGCAGCAGCGATGGATTCATAGTTCCTCCCAATAAAGATGGGGCCTCTCCGGAGGGGACTTCCAAAGGACCGGC GCACTTGGTCACTAGTCTATAGAAGGTGACACGGGGATGACAACCAACGGGACAGCTAACACCCGGTGGCCCATTCTGAGTCGATATAAGCAGTGGTCATCGTGTGTAACACGTGTGTGACATCTGAT GCTGTTCTCAAAAGAGAGACTCTGACATTTGGTTTTTTTTTTTTTTTTTTAACTTGAATTTTTAGGTCAGCGCAGGGGAGAAAGCTCCCCCTGTGCCCCAGTCTTTCCCGTCTTTCCCCTCAGATGGA CACTTCATTATGTTAATGAACGAGATAAGATGAAAATGGCGCTCATTGTGGCCTTGTTGAGTTAGGTTGTGATTAACAGCTCTGATGCTCTGTTACTAGAATCACGAGGACCTGATTTTTCTTTCTTT TTTTTTTTTTAAAAAAAAAAGAGGCCGGAACTATTGTTTGGAATTAGTAACAATGCTGCATCTAGATTGGAGTGCTGCCCAGCCGTAGAAGCAGAGCAGAACTGTATCCCATAGCGGTGCGCGGTCAC TCGCAACCTGAGTTCACCACAGCGAGCATAGCTGTGAAAAGCAAAAGCAAAACAACAGAATTAATAATCTGACGGTGGGGAATTCTAGAATTATATGCTAAATGCATATTTTATGATTTGCTGTATTA ACTGATGATAAAACTAATGGCAGAAAAAAAAAGAATTGAACAATTTCTATGTCATGTACAGATACTAGCATTGCGCATATAGTCTGCTTTTTGTTCCTCCAGAATTTGAGTCCTGTTAATGTAGTGGC AAAGAAGAAATTTTCCTTTTCTTTTGTGCTAGTCTTGCAAGTTTGTCTACCAGTAAAAGAGCAAAGTTTCCTTCCTTTCTTGTTTTCTTTCTTTTTATTTGTTCTTTTGTCCCCTCTCCCCCCACCCC ACCTTTTTATTTTTCCTTTAAAAATTCACCTGGCAAAAAATAATAATAATAAATAAATAAATGAAGCTATCACTTTATAAGAATCATTTTCTAGTAATGCAAACAAATTATTTTTTAACAAAAAATAA AATAAAATAAATAAAATTAGACTTCCTTCCCTCCATATATATCTATCTATCTATATTTATCCAGCCCGAGTATTTCCAATGTCATTTTTGCAAATTAGAGCAGGACAAATTTTACATTTCCAGGGCAC ATCTGTTGTAATGCGAAGCATTATTTGGCAAGCAGTTCATCACCAAGGCAGTAGCTATGATTCTAGAAGCTAAGAGGTGTCTATAGAGCTAGAGGGGGCTTCTGCATGTGAAATGCTGTAATTCGTAG GCGTTAAAAGTGCTGAATGGGCAGTCTGACCCCCACGTGGGCACCTGCACTACCAATTGTTAGAGGAAATTCACTCCCTCCTAGTGAGAGTTGAAAGGTCAAATTATTTTGAGGTAATTCTTTTTTTT TAAAGTTTTCTGTTAACAGGAAAATTTATTTATTTGACAGGATTTTAAGTAATGTAGAGATACAAATGGTAAATTAGCAGCACATATAATTTTTTTTAAATTTATGATCCATTTTGTATGGTCTCAAG TTGGATGACCTCATTACTAATATTTGTTGTAAAAGTGAAACTTGTTTGCCGACCAATAAACAACTGATTGAGATTTAGAAGAGATGGCTTTGACGTATGTACTATATTATCAAGTCCTCTTTTGACTT TCCTTGCCTTTCCTTTTCTTTGTTTTCATAATATAAACTCTTCTTAACCTCTGTGACCCAAGTGAGCAACACACACACACACACACACACACACACACTCTCACACTCAGATATATATCTGACTTGAA TATCCAAACACAACAGTACAGATTTTTGCAGACAAAGTTGATGCATAGCACCCACTCAAGTGGGATAAGGAAGATCACTCATCTCTAGTCACTAGGCTTAAGGCTAAAGACAGTCATCCAGTGGTTTA AATATCACTTGTGATGCGGCCATCTCTCAGGGCCCCTTATTGTAATCTTTATTCTAATGGAGGAATTTGGAAATTTAAATTTCCTCAGTTGGCTAAGAAGCACAATAGTAAAAGCAAAGACCTTATTC ATTGTACCAGAAGAATATAAGGTCATTAACATCGACACACTGTGTTAGTTTTCTCTATGGCCACCTCAAACAAAATCTGTTGTGTTGGTTCTCCTCCATCCCTCTGACTCCCTTTCTGTAGTCTCTGA CACCTCACCCTGCCCCAATGCATATTTCCCACCTTTATGCCTCCTATGTAAGACCTTTTTACTTTGTTTTTGTCTTCTTCAATGTATGGGTACTGGTGAAGGACAAAAGAATTCCTTCAAAAGAACTT TGTAGATCTTTCTATTCCTACACTACCAATGTGTCAGATCAAGGAGCCCCACGTAGAATAAAGCTCAAATGAACTTGCCAAAGTATATTTTCCCTTGTAGTATATCCTTGGGCTTACTTTACAAAAGC CCACGCACTAGCTATCTCTAAATGATATCTTAAATCAAGGTGAGAGGCGTTGAGAGTGTGACCAGCCAGTCTTCCATAGACACTGTAAAGTCTGTGGTAGAGAGGAAGTTGTGCACCCATTAATCTGA AAGTCATTTCAAAAGAATCCATGGATCATTTGATTTTAGCCAGATGATGGCAATATTTTCTTGAAATCCATAAACATTTTAATTTGGAAGAGAAACATAAGCATTAGAAGTAATTAGTTTTCTCACGA CATGGTTTGGGAATATTCCCCACATTACCGATAACCCACCCGATACCTATAAAAAAAATTCCCTCAGTGAGCAAACCTAAGTCAGCCTCAGAAATAAGGCTATTGTTTGTGGAGTGCTAACACTTGTG CTTGATTTAAAAAAATACTATCCCAAAGGAAAGCAATATCAGTAAAAGGCCGTTTCATGAGACAGTGGCGACCCTACTTCAGTCCAGCTCTTCAATCGTCTGTAATCTGGCATTACTACTTTCCTGTG TGGTGCTGTGTGTTTCGTTATCCAGAACTTGAAAGAGGTAGCCTTCCCATTTCTACCGGGAACAACCTGAAGAAAGATCACTTGAATACATCAACTGGTATCCAAGGCCTCTGCCTACTGTGCGCTAA CGTTGCTCTTGCATCAAGACGAAAGGGCCATTGGCGACCTCTCCTCTCATACATCATAACTGCCGTGCTTCAGAGAGTTAATCCTGTGGGAATCAGACCAACATCATTTAAAAGGACAATTAATAGAA TCAATATGCAGGGAGATCTTATACTATGCAACAGCAGAATGTTCTCCTCACCTTGAAAAACCTTTGCTATGCGACTCTAATTAAACAGAAGAAACAGTAGGTAACGTACGTGACTGTGTCTCATTTCA GTAGAAGTGTGTATATTCATTTAGTCCTGATTATACCACCTACATTATAGTTCCTGACCCTTGCTTCCACCCGACTTTTCATGCAAAGGCACTGACACATTAATGCTAATAACTTTTTCTTCATTCTA GAACCTTTGGTTGATTCTAAGTCTTCAGTACAGGGCGGCATTCGTTGCGTGCTTATTTGCATATTTTACCAGAAGTAAATTTCTACCAAACAGACTCAGTGTGCATACATAGCACATTATTCAGCCCA CTGAAAGAGAGAGAGTCATGTAAATGAAACAAGCCAATTATTGCTTTCTAGTAAATAATATTTTTGTAATATTTTACGCTTGAAGTTTTTACCTCTTTGAGGTCTTAAGTAATGAGATAATTTGTCAG GGCACTAACTTAAGGACCTCAGGTGTAATCGATTCTTGTATTGATGGCTTGTTGCATAGCCAATGATGCTAATTGATAATATTTATAAGTAAATAGAAATTCAAAGCAGAAAATTGGTTGGAATTCAG TTAAATTGTGTGAACATCCCTCTTCGTTTTTAACACAGTAAATGTGAACATATGGGAGATAAATGTCGAAGCCCCGTGCTAGAATAATCTTAGTGAGTAAAATGAATTGGCCTGAGAACAATTATAAC TATATTAAAATAAAAATAAGCAGCCAAAGCAAAGGCAGCTAATTAAGTTAATCATAATTTCTTATTAAAGAAGGCCCATGGTGGTTCTAAATTAAATCATAGTTTATGAAATGCTGTTTTTAAGACCA CCTATACAATTTAAAAAATTGATGCACTAAAAATATCTTTTAAAAATTTGGGCTTTGAATTTTTTTTTTTTAATCGGAGCTGAGGACCGAACCCAGGGCCTTGAGCTTGTAGGCAAGCGCTCTACCAC TGAGCTAAATCCCCAACCCAAATTTGGGCTTTGAATCTTCAGTGTCAACAGTGTGATGAATCCTCTGACGTTAATGATAACTTTAAAACATGTTTGGAAGTAACTGTAGTTTTGTAGGAAAGGGGGAA AAGCTTTTGTCTAACAAACAATTGTTAGCGGAATTGTATCTATGCCATAGAAATGAAAGTCTTTAGTTTTTAAAGTTGTTCATTAACACTGTATAAAACTCCAGTACTTAACATATTTTGGAGGAAAA CAAAAAAAAACACCAATAAAAACAACAAACAAACAAAAGTCACTTTAACATAAATGAATGTCAACTTAAAGAGTCAAAAATAATCTGAAATTCTTATCTGATAGGAATTGGTACATTAGCCATAGTCC TTTACTCCAAGACAAGTAATTGATATAAAATTCTATGTACAAACTTCTCAGTATATTATAGGCCAGAATACAAATATTTAATTGTTTATTTTTAATATGTCATAATCTTTCACATAAACAATTACTAT GCATTCCTAATTAGAATCTATATATTAGATCTTTCCATGTCAAATTTTAGAAAGAAGACAGAAGGAACACAAATACATAGAAAAACAGGTTTGGGAAACATTTTCATATAAATGAATTCTATGTAAAA AAAAATTTTTTTAAGAGTTCATAAAATAGAGTCCAAAGACTAAACTCAGTTTTGCAATCAGGAAATTTGTCTGTTTTAAACCATCTGAAAAACATGTTTTTAGACATCTGAACTTTCATTTATAATCT AAAAGTGTTGATAGTTGGTATAGCTGTTTGTGTCCTGGTTAAGCCATAGGGGACATTTATCTAAGGCATCCATTTACCTTGATGACGTCATGCTTGCTTTACAAAGGAAAATGGTCTTTAAATTGTCA CCTGTATATGTGTTTGAACAGTCTAATTTTTAATAAGATTTCAGAGGAAGTAACTTTTTTACAATTAGCCAGGGAGTTAGTTTTGTATATTCTCATTTTAAGTAATCATTATAGTCTTCTAAAAAAAT TATAATCATCAGTTTGCCTGTAGCACTTTTAAGTTGTTATTAAAAATGCCTCAATTCCAAATATGTTTTTGAACCTTTACCTGTCTTACCAGTATGTTGACTGTATTTTTCTTCATTTGTAATTTCCC TGCCACTGGAGAACATGATAAAAGGAATTGGGGACTGATTTATGTGACGATTAAGAAACAGCTCACGGACACCACCTTCTTTTAATCAGCTAGGAGTTTTAACTGTAGTCCGAACAGTTCCAATCAGA ACCTGTTTGGCAAAGTTTTCCCAAATACACAATATCTACATTAGCATTTTAAAGGAAAGGTTTCAGGGGAAGGGGTGAAATTGCTTATAATGATTAAAAAGCTGTTGTGCCCAATACTTCTGATGTGT TAAGAAAAAAATGTAAATTCGTATATTTTCATCATTCTAAAACCACAGAAAATACAACATGCTGTTAGCCTTTTTTTTTTTATATTTCTCACGCGGTTAACTCCTGTTGCACAGAAATTTCAATACTT CCTAATTGTCTCTAAAATATAAGTATTTCTCATCAGTTCACCTTCACCCTCTGATCTCCTGACTATTGAATACCTACACACTTAATGCAACCCGTAGCTTTGTGATTTTTACAGCTTTATTATGACCC TCTCTAGTAAAATTGATATTAGAAGTATATGCATTGTGCAAAATAATTAACAACCTATAGTCTTATGACAAAATAGCCAGGCACATATATACACACATATATATCTATACCTGAATATTGTTGACTTA TCAAATTACCACCATGCTGACAGTTGTCGATCACGGTAGTCACTTCCCACAATTCTGCAAAGAACTCTACATATTCTAGACTATTGAAATACTTGACAATACAACGCATCAGAATGGATTCCCAGTGC ATCTTGAGAACCCAATAGTTTTATATCGAAGTGCTACCTTTGAGCTAAGGAGGAAGGTGCAAAAAAAAATCTAATTAACAGAGGAATTTAGATTTGTTTTACTGGCCCAACACTGGAAAATTCTTACA ACGTGAATCAGATATAGCTTCTTAACTGCATACAGATGACAAGGTAATGGTGTCAACCTTAAAAATTGCTTTGTTCCCACTGATGTTTGAAACAGGCACAATAATATTGCCACCCTTATTGATTGACT TCAAAAGATGTCTCATGGACCTAGAGAATCATGACACAGGGGAGCAGTGTGGTTCTTCAGAGTTGGGGCACAGTGGCTATAACAGTGTGGCCTTAATGCTGAAAGCTGATTATCATTGTACAGTCTTG CTTTCAATGCCTCAACTTTCAATTGTCCTAATGGCTGATGGTTTGATTGACATTTTGAATCACAAAGGACAAAGAAAATCACTGAATGCTGGCTTTCACACACCAGTGGAAAGTAAAGATATCCTATT CTATCCTGAATCATAAAAAATTGTGTTGTCCTGCAGAATTGTAGACAGCTGTGTGTGTGTGCGTGTGCTTTGTAGATATGTCTCCGTCATCTATGTATTCTAACACCAGTGTCAATATTCTAACATCT AATACTTCCTGTAAACTATAAATTCAAAAAAACTGTAGAACCAGATTTTTTTCTCCCTTGGCTTTTCTAAAGGCTTTGGAACAGGACAGATAACTGGGAAAGTTTTCCATATTGTATTTATTCTTGAC AAAGATTCACATTTAATTCATGATATAAGTCTGTTAAAAATAGCTTATTTTGAAGACTAACAACTGATCGAGCTACTCCTCACTGATATGAAAAATCACTTACAGAAGCAAATACATAGCTATTGTAA CATTGGTCTCATAGAATTCTTCTATATTCACATATAACACTATTCTGGCCATACGCACTGATAAATTTCAAGGTACTCAACCCCCACTACCCTCTTGTACAATCCTTTTATCCTTTTTAAAAACTATG CTTTGTACAATCACGTGTAAAATCATGAGCTACAAAACTCAATAAAACATAAGTAAACAACCA
hide sequence
RefSeq Acc Id:
XM_039091579 ⟹ XP_038947507
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,367,627 - 27,104,056 (-) NCBI
RefSeq Acc Id:
XM_039091582 ⟹ XP_038947510
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,367,627 - 27,104,056 (-) NCBI
RefSeq Acc Id:
XM_039091584 ⟹ XP_038947512
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,369,866 - 27,104,059 (-) NCBI
RefSeq Acc Id:
XM_039091585 ⟹ XP_038947513
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,369,866 - 27,104,057 (-) NCBI
RefSeq Acc Id:
XM_039091587 ⟹ XP_038947515
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI mRatBN7.2 14 26,369,866 - 27,104,056 (-) NCBI
RefSeq Acc Id:
XM_063272818 ⟹ XP_063128888
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,129 (-) NCBI
RefSeq Acc Id:
XM_063272819 ⟹ XP_063128889
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,125 (-) NCBI
RefSeq Acc Id:
XM_063272820 ⟹ XP_063128890
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272821 ⟹ XP_063128891
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272822 ⟹ XP_063128892
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272823 ⟹ XP_063128893
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272824 ⟹ XP_063128894
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,125 (-) NCBI
RefSeq Acc Id:
XM_063272825 ⟹ XP_063128895
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,125 (-) NCBI
RefSeq Acc Id:
XM_063272826 ⟹ XP_063128896
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,129 (-) NCBI
RefSeq Acc Id:
XM_063272827 ⟹ XP_063128897
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,125 (-) NCBI
RefSeq Acc Id:
XM_063272828 ⟹ XP_063128898
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272829 ⟹ XP_063128899
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272830 ⟹ XP_063128900
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272831 ⟹ XP_063128901
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,720,511 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272832 ⟹ XP_063128902
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,690,891 - 27,458,129 (-) NCBI
RefSeq Acc Id:
XM_063272833 ⟹ XP_063128903
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,690,891 - 27,458,132 (-) NCBI
RefSeq Acc Id:
XM_063272834 ⟹ XP_063128904
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,690,891 - 27,458,125 (-) NCBI
RefSeq Acc Id:
XM_063272835 ⟹ XP_063128905
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 14 26,690,891 - 27,458,132 (-) NCBI
RefSeq Acc Id:
NP_570835 ⟸ NM_130822
- Peptide Label:
precursor
- UniProtKB:
Q9Z173 (UniProtKB/Swiss-Prot), Q4LDM8 (UniProtKB/Swiss-Prot), Q4LDM7 (UniProtKB/Swiss-Prot), Q4LDM6 (UniProtKB/Swiss-Prot), Q4LDM5 (UniProtKB/Swiss-Prot), Q4LDM4 (UniProtKB/Swiss-Prot), O88929 (UniProtKB/Swiss-Prot), O88928 (UniProtKB/Swiss-Prot), O88927 (UniProtKB/Swiss-Prot), O88926 (UniProtKB/Swiss-Prot), O88925 (UniProtKB/Swiss-Prot), O88924 (UniProtKB/Swiss-Prot), A0A8I6GLK1 (UniProtKB/TrEMBL)
- Sequence:
MCPPQLFILMMLLAPVVHGGKHNERHPALAAPLRHAEHSPGGPLPPRHLLQQPAAERSTAHRGQGPRGTARGVRGPGAPGAQIAAQAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQYECVPYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSK DDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGTWDTAYDKRSASNAFMI CGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGPVHHGQVSYISPPIHLDSDLERPPVRGISTTGPLGMGSTTTSTTL RTTTWNLGRSTTPSLPGRRNRSTSTPSPAIEVLDVTTHLPSAASQIPAMEESCEAVEAREIMWFKTRQGQVAKQSCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKSGETAANIAR ELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLDTVEESAFVLADNLLKTDIVRENTDNIQLEV ARLSTEGNLEDLKFPENTGHGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEAMSTNHSVIVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSKRTMT GYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTW MFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNINYEDNRPFIKSWVIGAIALLCL LGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSASLNRGSYLPCIQAC VTYLEGLLNNARDTSVMDTLPLNGNHGNSYSIAGGEYLSNCVQIIDRGYNHNETALEKKILKELTSNYIPSYLNNHERSSEQNRNMMNKLVDNLGSGSEDDAIVLDDAASFNHEESLGLELIHEESDA PLLPPRVYSTDNHQPHHYSRRRLPQDHSESFFPLLTDEHTEDPQSPHRDSLYTSMPALAGVPAADSVTTSTQTEAAAAKGGDAEDVYYKSMPNLGSRNHVHPLHAYYQLGRGSSDGFIVPPNKDGASP EGTSKGPAHLVTSL
hide sequence
RefSeq Acc Id:
XP_008768192 ⟸ XM_008769970
- Peptide Label:
isoform X2
- UniProtKB:
D4AAL4 (UniProtKB/TrEMBL), A6JCT7 (UniProtKB/TrEMBL)
- Sequence:
MCPPQLFILMMLLAPVVHGGKHNERHPALAAPLRHAEHSPGGPLPPRHLLQQPAAERSTAHRGQ GPRGTARGVRGPGAPGAQIAAQAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGRTDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQYECV PYKVEQKVFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSKDDFIAGRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYHDT SPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGTWDTAYDKRSASNAFMICGILYVVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYIAAVDYNPRDNLLYVWN NYHVVKYSLDFGPLDSRSGPVHHGQVSYISPPIHLDSDLERPPVRGISTTGPLGMGSTTTSTTLRTTTWNLGRSTTPSLPGRRNRSTSTPSPAIEVLDVTTHLPSAASQIPAMEESCEAVEAREIMWF KTRQGQVAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKSGETAANIARELAEQTRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQA MVETVNNLLQPQALNAWRDLTTSDQLRAATMLLDTVEESAFVLADNLLKTDIVRENTDNIQLEVARLSTEGNLEDLKFPENTGHGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLG TEAMSTNHSVIVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWSTQGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLL ICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEGVQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFI WSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNINYEDNRPFIKSWVIGAIALLCLLGLTWAFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTE SSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSASLNRGTMANHLMSNALLRPHGTNNPYNTLLGEPAVCNNPSISMYNAQEGLLNNARDTSVMDTLPLNGNHGNSYSIAGG EYLSNCVQIIDRGYNHNETALEKKILKELTSNYIPSYLNNHERSSEQNRNMMNKLVDNLGSGSEDDAIVLDDAASFNHEESLGLELIHEESDAPLLPPRVYSTDNHQPHHYSRRRLPQDHSESFFPLL TDEHTEDPQSPHRDSLYTSMPALAGVPAADSVTTSTQTEAAAAKGGDAEDVYYKSMPNLGSRNHVHPLHAYYQLGRGSSDGFIVPPNKDGASPEGTSKGPAHLVTSL
hide sequence
RefSeq Acc Id:
XP_017454548 ⟸ XM_017599059
- Peptide Label:
isoform X1
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
- Sequence:
MCPPQLFILMMLLAPVVHGGKHNERHPALAAPLRHAEHSPGGPLPPRHLLQQPAAERSTAHRGQGPRGTARGVRGPGAPGAQIAAQAFSRAPIPMAVVRRELSCESYPIELRCPGTDVIMIESANYGR TDDKICDSDPAQMENIRCYLPDAYKIMSQRCNNRTQCAVVAGPDVFPDPCPGTYKYLEVQYECVPYIFLCPGLLKGVYQSEHLFESDHQSGAWCKDPLQASDKIYYMPWTPYRTDTLTEYSSKDDFIA GRPTTTYKLPHRVDGTGFVVYDGALFFNKERTRNIVKFDLRTRIKSGEAIIANANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEQNNGKIVISQLNPYTLRIEGTWDTAYDKRSASNAFMICGILY VVKSVYEDDDNEATGNKIDYIYNTDQSKDSLVDVPFPNSYQYIAAVDYNPRDNLLYVWNNYHVVKYSLDFGPLDSRSGPVHHGQVSYISPPIHLDSDLERPPVRGISTTGPLGMGSTTTSTTLRTTTW NLGRSTTPSLPGRRNRSTSTPSPAIEVLDVTTHLPSAASQIPAMEESCEAVEAREIMWFKTRQGQVAKQPCPAGTIGVSTYLCLAPDGIWDPQGPDLSNCSSPWVNHITQKLKSGETAANIARELAEQ TRNHLNAGDITYSVRAMDQLVGLLDVQLRNLTPGGKDSAARSLNKLQKRERSCRAYVQAMVETVNNLLQPQALNAWRDLTTSDQLRAATMLLDTVEESAFVLADNLLKTDIVRENTDNIQLEVARLST EGNLEDLKFPENTGHGSTIQLSANTLKQNGRNGEIRVAFVLYNNLGPYLSTENASMKLGTEAMSTNHSVIVNSPVITAAINKEFSNKVYLADPVVFTVKHIKQSEENFNPNCSFWSYSKRTMTGYWST QGCRLLTTNKTHTTCSCNHLTNFAVLMAHVEVKHSDAVHDLLLDVITWVGILLSLVCLLICIFTFCFFRGLQSDRNTIHKNLCISLFVAELLFLIGINRTDQPIACAVFAALLHFFFLAAFTWMFLEG VQLYIMLVEVFESEHSRRKYFYLVGYGMPALIVAVSAAVDYRSYGTDKVCWLRLDTYFIWSFIGPATLIIMLNVIFLGIALYKMFHHTAILKPESGCLDNINYEDNRPFIKSWVIGAIALLCLLGLTW AFGLMYINESTVIMAYLFTIFNSLQGMFIFIFHCVLQKKVRKEYGKCLRTHCCSGKSTESSIGSGKTSGSRTPGRYSTGSQSRIRRMWNDTVRKQSESSFITGDINSSASLNRGTMANHLMSNALLRP HGTNNPYNTLLGEPAVCNNPSISMYNAQEPYRETKGLLNNARDTSVMDTLPLNGNHGNSYSIAGGEYLSNCVQIIDRGYNHNETALEKKILKELTSNYIPSYLNNHERSSEQNRNMMNKLVDNLGSGS EDDAIVLDDAASFNHEESLGLELIHEESDAPLLPPRVYSTDNHQPHHYSRRRLPQDHSESFFPLLTDEHTEDPQSPHRDSLYTSMPALAGVPAADSVTTSTQTEAAAAKGGDAEDVYYKSMPNLGSRN HVHPLHAYYQLGRGSSDGFIVPPNKDGASPEGTSKGPAHLVTSL
hide sequence
Ensembl Acc Id:
ENSRNOP00000056687 ⟸ ENSRNOT00000059942
Ensembl Acc Id:
ENSRNOP00000039467 ⟸ ENSRNOT00000048175
Ensembl Acc Id:
ENSRNOP00000045365 ⟸ ENSRNOT00000044659
RefSeq Acc Id:
XP_038947510 ⟸ XM_039091582
- Peptide Label:
isoform X8
- UniProtKB:
A0A8I5ZV15 (UniProtKB/TrEMBL), A6JCT5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038947507 ⟸ XM_039091579
- Peptide Label:
isoform X6
- UniProtKB:
A6JCT5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038947512 ⟸ XM_039091584
- Peptide Label:
isoform X14
- UniProtKB:
F1LRG7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038947513 ⟸ XM_039091585
- Peptide Label:
isoform X15
- UniProtKB:
A6JCU0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038947515 ⟸ XM_039091587
- Peptide Label:
isoform X16
- UniProtKB:
A0A8I5ZWD6 (UniProtKB/TrEMBL), A6JCU0 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000079850 ⟸ ENSRNOT00000112920
Ensembl Acc Id:
ENSRNOP00000084026 ⟸ ENSRNOT00000103416
Ensembl Acc Id:
ENSRNOP00000096360 ⟸ ENSRNOT00000100277
Ensembl Acc Id:
ENSRNOP00000076473 ⟸ ENSRNOT00000112583
Ensembl Acc Id:
ENSRNOP00000083229 ⟸ ENSRNOT00000112088
Ensembl Acc Id:
ENSRNOP00000092249 ⟸ ENSRNOT00000106702
RefSeq Acc Id:
XP_063128905 ⟸ XM_063272835
- Peptide Label:
isoform X20
- UniProtKB:
A6JCU0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128903 ⟸ XM_063272833
- Peptide Label:
isoform X18
- UniProtKB:
A6JCU0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128902 ⟸ XM_063272832
- Peptide Label:
isoform X17
- UniProtKB:
A6JCU0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128904 ⟸ XM_063272834
- Peptide Label:
isoform X19
- UniProtKB:
A6JCU0 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128901 ⟸ XM_063272831
- Peptide Label:
isoform X13
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128900 ⟸ XM_063272830
- Peptide Label:
isoform X12
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128899 ⟸ XM_063272829
- Peptide Label:
isoform X11
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128898 ⟸ XM_063272828
- Peptide Label:
isoform X10
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128893 ⟸ XM_063272823
- Peptide Label:
isoform X7
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128890 ⟸ XM_063272820
- Peptide Label:
isoform X3
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128892 ⟸ XM_063272822
- Peptide Label:
isoform X5
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128891 ⟸ XM_063272821
- Peptide Label:
isoform X4
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128896 ⟸ XM_063272826
- Peptide Label:
isoform X8
- UniProtKB:
A6JCT5 (UniProtKB/TrEMBL), A0A8I5ZV15 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128888 ⟸ XM_063272818
- Peptide Label:
isoform X1
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128895 ⟸ XM_063272825
- Peptide Label:
isoform X7
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128897 ⟸ XM_063272827
- Peptide Label:
isoform X9
- UniProtKB:
A6JCT5 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128894 ⟸ XM_063272824
- Peptide Label:
isoform X7
- UniProtKB:
A6JCT4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063128889 ⟸ XM_063272819
- Peptide Label:
isoform X1
- UniProtKB:
A6JCT7 (UniProtKB/TrEMBL)
BioCyc Gene
G2FUF-16030
BioCyc
Ensembl Genes
ENSRNOG00000030149
Ensembl, ENTREZGENE
Ensembl Transcript
ENSRNOT00000044659
ENTREZGENE
ENSRNOT00000048175
ENTREZGENE
ENSRNOT00000059942
ENTREZGENE
ENSRNOT00000100277
ENTREZGENE
ENSRNOT00000112088
ENTREZGENE
ENSRNOT00000131643
ENTREZGENE
Gene3D-CATH
1.25.40.610
UniProtKB/Swiss-Prot
2.60.120.740
UniProtKB/Swiss-Prot
2.60.220.50
UniProtKB/Swiss-Prot
4.10.1240.10
UniProtKB/Swiss-Prot
Rhodopsin 7-helix transmembrane proteins
UniProtKB/Swiss-Prot
InterPro
GAIN_dom_N
UniProtKB/Swiss-Prot
GAIN_dom_sf
UniProtKB/Swiss-Prot
GPCR_2-like
UniProtKB/Swiss-Prot
GPCR_2_extracell_dom_sf
UniProtKB/Swiss-Prot
GPCR_2_extracellular_dom
UniProtKB/Swiss-Prot
GPCR_2_latrophilin
UniProtKB/Swiss-Prot
GPCR_2_latrophilin_rcpt_C
UniProtKB/Swiss-Prot
GPCR_2_secretin-like
UniProtKB/Swiss-Prot
GPCR_2_secretin-like_CS
UniProtKB/Swiss-Prot
GPS
UniProtKB/Swiss-Prot
Lectin_gal-bd_dom
UniProtKB/Swiss-Prot
Lectin_gal-bd_sf
UniProtKB/Swiss-Prot
Olfac-like_dom
UniProtKB/Swiss-Prot
KEGG Report
rno:170641
UniProtKB/Swiss-Prot
NCBI Gene
170641
ENTREZGENE
PANTHER
ADHESION G-PROTEIN COUPLED RECEPTOR
UniProtKB/Swiss-Prot
PTHR12011:SF60
UniProtKB/Swiss-Prot
Pfam
7tm_2
UniProtKB/Swiss-Prot
GAIN
UniProtKB/Swiss-Prot
Gal_Lectin
UniProtKB/Swiss-Prot
GPS
UniProtKB/Swiss-Prot
HRM
UniProtKB/Swiss-Prot
Latrophilin
UniProtKB/Swiss-Prot
OLF
UniProtKB/Swiss-Prot
PhenoGen
Adgrl3
PhenoGen
PRINTS
GPCRSECRETIN
UniProtKB/Swiss-Prot
LATROPHILIN
UniProtKB/Swiss-Prot
PROSITE
G_PROTEIN_RECEP_F2_2
UniProtKB/Swiss-Prot
G_PROTEIN_RECEP_F2_3
UniProtKB/Swiss-Prot
G_PROTEIN_RECEP_F2_4
UniProtKB/Swiss-Prot
GPS
UniProtKB/Swiss-Prot
OLF
UniProtKB/Swiss-Prot
SUEL_LECTIN
UniProtKB/Swiss-Prot
RatGTEx
ENSRNOG00000030149
RatGTEx
SMART
GPS
UniProtKB/Swiss-Prot
HormR
UniProtKB/Swiss-Prot
OLF
UniProtKB/Swiss-Prot
Superfamily-SCOP
Family A G protein-coupled receptor-like
UniProtKB/Swiss-Prot
UniProt
A0A8I5XV01_RAT
UniProtKB/TrEMBL
A0A8I5ZNG3_RAT
UniProtKB/TrEMBL
A0A8I5ZV15
ENTREZGENE, UniProtKB/TrEMBL
A0A8I5ZWD6
ENTREZGENE, UniProtKB/TrEMBL
A0A8I6AHH3_RAT
UniProtKB/TrEMBL
A0A8I6GLK1
ENTREZGENE, UniProtKB/TrEMBL
A6JCT4
ENTREZGENE, UniProtKB/TrEMBL
A6JCT5
ENTREZGENE, UniProtKB/TrEMBL
A6JCT7
ENTREZGENE, UniProtKB/TrEMBL
A6JCU0
ENTREZGENE, UniProtKB/TrEMBL
A6JCU1_RAT
UniProtKB/TrEMBL
AGRL3_RAT
UniProtKB/Swiss-Prot
D3ZH59_RAT
UniProtKB/TrEMBL
D4AAL4
ENTREZGENE, UniProtKB/TrEMBL
F1LRG7
ENTREZGENE, UniProtKB/TrEMBL
O88924
ENTREZGENE
O88925
ENTREZGENE
O88926
ENTREZGENE
O88927
ENTREZGENE
O88928
ENTREZGENE
O88929
ENTREZGENE
Q4LDM4
ENTREZGENE
Q4LDM5
ENTREZGENE
Q4LDM6
ENTREZGENE
Q4LDM7
ENTREZGENE
Q4LDM8
ENTREZGENE
Q9Z173
ENTREZGENE
UniProt Secondary
O88924
UniProtKB/Swiss-Prot
O88925
UniProtKB/Swiss-Prot
O88926
UniProtKB/Swiss-Prot
O88927
UniProtKB/Swiss-Prot
O88928
UniProtKB/Swiss-Prot
O88929
UniProtKB/Swiss-Prot
Q4LDM4
UniProtKB/Swiss-Prot
Q4LDM5
UniProtKB/Swiss-Prot
Q4LDM6
UniProtKB/Swiss-Prot
Q4LDM7
UniProtKB/Swiss-Prot
Q4LDM8
UniProtKB/Swiss-Prot
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2006-03-30
Lphn3
latrophilin 3
calcium-independent alpha-latrotoxin receptor homolog 3
Name updated
1299863
APPROVED
2004-09-10
Lphn3
calcium-independent alpha-latrotoxin receptor homolog 3
Cirl3
Symbol and Name updated
1299863
APPROVED
2002-08-07
Cirl3
calcium-independent alpha-latrotoxin receptor homolog 3
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_expression
predominantly expressed in brain
632388